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ABSTRACT 
 
 
Triacylglycerols are the predominant molecules of energy storage in eukaryotes.  
Triacylglycerol synthesis is catalyzed by acyl-CoA:diacylglycerol acyltransferase (DGAT) 
enzymes, DGAT1 and DGAT2.  Although the use of molecular tools, including targeted 
disruption of either DGAT enzyme, has shed light on their metabolic functions, little is known 
about the mechanisms responsible for regulating DGAT activity.  Several lines of evidence 
from previous studies have suggested that DGAT1, but not DGAT2, is subject to regulation by 
phosphorylation and that protein kinase A (PKA)-dependent pathways are likely involved.  In 
this study, the role of PKA in regulating DGAT activity and triacylglycerol synthesis during 
lipolysis was investigated.  By using 3T3-L1 adipocytes, in vitro DGAT activity was shown to 
increase 2 fold during lipolysis.  This data suggests that PKA might phosphorylate and activate 
DGAT1 during lipolysis to promote the recycling/re-esterification of excessive free fatty acids 
into triacylglycerols before they reach toxic levels within the cell.  Additionally, high-
performance liquid chromatography – electrospray ionization – mass spectrometry/mass 
spectrometry was exploited to identify PKA phosphorylation sites of DGAT1, and serine-17, -
20 and -25 were identified as potential PKA phosphorylation sites using this methodology.  The 
functional importance of these three potential phosphorylation sites was examined.  Mutations 
of these sites to alanines (to prevent phosphorylation) or aspartates (to mimic phosphorylation) 
gave rise to enzymes functioning similarly to wild-type DGAT1.  These phosphorylation sites 
appeared to be functionally silent as they were not involved in regulating DGAT1 activity, 
multimer formation, or enzyme stability.  However, PKA phosphorylation at these three sites 
seemed to play a role in affinity of DGAT1 for its diacylglycerol substrate.  These results 
indicate the existence of other unidentified, functionally active PKA phosphorylation sites or 
phosphorylation sites of other kinases, which are involved in regulating DGAT1.      
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1.0 INTRODUCTION 
 
As a result of our society obtaining overly rich nutrition and our preponderance to 
sedentary lifestyles, obesity has rapidly become a global health issue.  In many incidences of 
obesity, individuals also develop insulin resistance, which can lead to type 2 diabetes mellitus. 
These conditions in turn predispose to hyperlipidemia and atherosclerotic coronary heart 
disease.  These associated conditions—obesity, insulin resistance, and atherosclerosis—are 
components of the metabolic syndrome, which is one of the most prevalent non-communicable 
diseases and poses a significant threat to public health (Zimmet et al., 2001).  Therefore, basic 
research on the pathophysiological mechanisms underlying obesity and obesity-associated 
diseases is essential for achieving effective interventions for these diseases.  
 Triacylglycerols are a class of neutral lipids that represent the major storage form of 
energy in eukaryotic organisms.  However, an imbalance between energy intake and 
expenditure can lead to excessive accumulation of triacylglycerols in adipose tissue resulting in 
obesity.  Excessive accumulation of triacylglycerols in non-adipose tissues, such as skeletal 
muscle, liver, heart, and pancreatic beta cells, is associated with insulin resistance and can lead 
to type 2 diabetes mellitus and cardiovascular disease (Unger, 2002; Friedman, 2002).  
The final step of triacylglycerol biosynthesis is catalyzed by the microsomal enzyme 
acyl-CoA:diacylglycerol acyltransferase (DGAT, EC 2.3.1.20).  Two DGAT enzymes have 
been identified (DGAT1 and DGAT2), and studies have clearly demonstrated their unique roles 
in lipid metabolism (Smith et al, 2000; Chen et al., 2002a; Chen et al., 2003; Stone et al., 2004; 
Wang et al., 2007).  However, the mechanisms by which these enzymes are regulated are 
poorly understood.  DGAT1 has the consensus sequences for two protein kinase A (PKA) 
phosphorylation sites that are not present in DGAT2.  In previous studies, only DGAT1, but not 
DGAT2, appeared to be phosphorylated (Stone et al., unpublished observations).  Using a 
candidate kinase approach, PKA has been identified as one possible kinase that could 
phosphorylate DGAT1 and inhibit its in vitro activity.  This preliminary data indicates that 
DGAT1, but not DGAT2, is subject to regulation by phosphorylation and that PKA-dependent 
pathways are likely involved.  We hypothesize that during lipolysis in adipose tissue, PKA 
would phosphorylate and inactivate DGAT1, which in turn would facilitate the efficient net 
release of stored energy by decreasing triacylglycerol synthesis.   
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The objective of my thesis was to examine the role that PKA has in regulating DGAT1 
activity and triacylglycerol synthesis during lipolysis.  Additionally, my goal was to identify 
PKA phosphorylation sites of DGAT1 by mass spectrometry (MS) and determine their 
functional importance. 
  
3 
2.0 LITERATURE REVIEW 
 
 
2.1 Triacylglycerols  
Triacylglycerols are a class of neutral lipids and are the predominant storage form of 
metabolic energy in eukaryotic organisms (Coleman et al., 2003; Hertzel et al., 2008; Yen et al., 
2008).  Triacylglycerols are composed of three fatty acids attached to a glycerol backbone by 
ester bonds.  Various triacylglycerols possess different physical and chemical properties, 
depending on their fatty acid compositions.  Triacylglycerols containing primarily saturated 
long-chain fatty acids tend to be solid at body temperature, and those containing unsaturated or 
short-chain fatty acids tend to be liquid.  Triacylglycerols are highly reduced molecules and can 
be stored in large quantities as they are anhydrous.  The highly reduced hydrocarbon tail of the 
fatty acid makes triacylglycerols an efficient fuel storage that can be readily oxidized to 
produce large quantities of ATP.  Moreover, the very hydrophobic nature of the hydrocarbon 
tail precludes concomitant storage of excess water, which in turn minimizes mass and spatial 
requirements of the organism.  The relatively straight, chain-like structure of the fatty acid 
further facilitates the dense packing of many molecules into each cell, maximizing the 
efficiency of energy storage.  Therefore, triacylglycerols store 6-fold more energy than the same 
amount of hydrated glycogen (Yen et al., 2008).  In plants, triacylglycerols are particularly 
abundant in oil-rich seeds and fruits, developing microspores and pollen grains (Murphy and 
Vance, 1999; Xu et al., 2008).  Triacylglycerols in microorganisms are present in a small 
number of cytosolic lipid droplets that also contain sterol esters (Murphy and Vance, 1999).  In 
mammals, adipose tissue serves as the major energy storage depot in the body and provides 
thermal insulation for organisms (Yen et al., 2008).  A typical adipocyte from adipose tissue 
contains one or a few large cytoplasmic triacylglycerol-rich lipid droplets that accounts for 
nearly the entire volume of the cell (Murphy and Vance, 1999).  Energy stored in the form of 
triacylglycerols can be utilized through lipolysis, the process by which triacylglycerols are 
hydrolyzed to glycerol and fatty acids.  Released fatty acids and glycerol enter the circulation 
and are utilized by tissues that require energy.  Triacylglycerols are also abundant in 
mammalian hepatocytes and enterocytes.  In addition to energy storage, in mammalian 
enterocytes and hepatocytes, triacylglycerols can be synthesized, assembled and secreted into 
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the circulation as chylomicrons from the intestine or very low-density-lipoproteins from the 
liver, which distribute dietary and endogenously synthesized fatty acids to peripheral tissues 
(Coleman et al., 2003; Yen et al., 2008).  Furthermore, triacylglycerol biosynthesis serves to 
protect cells from the potentially membrane-damaging effects of excessive fluxes of fatty acids 
and acyl-CoAs, because their incorporation into triacylglycerols converts them to a non-toxic 
compound that can be safely stored (Coleman et al., 2003). 
Although triacylglycerols play a variety of critical roles for normal physiology of 
eukaryotic organisms, an imbalance between energy intake and expenditure can lead to 
excessive accumulation of triacylglycerols in adipose tissue resulting in obesity.  Excessive 
accumulation of triacylglycerols in non-adipose tissues, such as skeletal muscle, liver, heart, 
and pancreatic beta cells, is associated with insulin resistance and can lead to type 2 diabetes 
mellitus, which in turn predispose to hyperlipidemia and atherosclerotic coronary heart disease 
(Unger, 2002; Friedman, 2002). 
 
 
2.2 Triacylglycerol Biosynthesis and DGAT Enzymes 
Triacylglycerol biosynthesis occurs mainly via two acyl-CoA dependent pathways: the 
Kennedy (or glycerol phosphate) pathway and the monoacylglycerol pathway (Lehner et al., 
1996; Yen et al., 2008) (Figure 2.1).  The glycerol phosphate pathway, which functions in most 
cell types, represents the de novo route to triacylglycerol formation.  On the other hand, the 
monoacylglycerol pathway accounts for the majority of triacylglycerol synthesis (~80%) in the 
small intestine, where most dietary triacylglycerols are absorbed as fatty acids and 
monoacylglycerols that require re-assembly to triacylglycerols (Buhman et al., 2002).  The final 
step of both pathways is catalyzed by DGAT enzymes.  DGAT catalyzes the formation of an 
ester bond between a long chain fatty acyl-CoA and the free hydroxyl group of sn-1,2 (2,3)-
diacylglycerol, but not sn-1,3-diacylglycerol, generating triacylglycerol (Lehner et al., 1993) 
(Figure 2.2).  It is important to note that the diacylglycerol synthesized from the 
monoacylglycerol pathway and the glycerol phosphate pathway are not metabolically 
equivalent, because the former is directed to triacylglycerol synthesis only whereas the latter 
may be utilized to synthesize either triacylglycerol or phospholipids (Charles et al., 2007).  The 
DGAT reaction is believed to occur mainly at the endoplasmic reticulum (ER), and newly
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synthesized triacylglycerols are thought to be channeled either into cytosolic lipid droplets for 
storage or triacylglycerol-rich lipoproteins for secretion into the circulation (Yen et al., 2008).  
In addition to the two acyl-CoA dependent pathways of triacylglycerol biosynthesis, an acyl-
CoA independent pathway has been reported in mouse small intestine, in which a fatty acyl 
moiety from one diacylglycerol can be transferred to a second diacylglycerol to synthesize 
triacylglycerol in a reaction catalyzed by diacylglycerol transacylase (Buhman et al., 2002). 
 
 
 
 
Figure 2.1 Metabolic Pathways of Triacylglycerol Biosynthesis.   
Triacylglycerol biosynthesis occurs via two predominant pathways: the Kennedy (or glycerol 
phosphate) pathway and the monoacylglycerol pathway.  DGAT1 and DGAT2 catalyze the 
final step of triacylglycerol synthesis.  GPAT: glycerol-phosphate acyltransferase; AGPAT: 
acylglycerol-phosphate acyltransferase; PAP: phosphatidic acid phosphohydrolase; MGAT: 
acyl-CoA:monoacylglycerol acyltransferase.  The diagram is taken from Yen et al. (2008). 
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2.3 Distinct Gene Families of DGAT Enzymes 
Two distinct DGAT genes have now been identified, Dgat1 and Dgat2, which share no 
sequence homology.  The gene encoding DGAT1 was identified by its sequence similarity to 
acyl-CoA:cholesterol acyltransferase (ACAT) enzymes, which catalyze cholesterol ester 
biosynthesis (Chang et al., 1993; Cases et al., 1998).  Both DGAT1 and ACAT enzymes belong 
to a large family of membrane-bound O-acyltransferases (Figure 2.3), which catalyzes the 
covalent joining of fatty acyl moieties onto the hydroxyl or thiol groups of lipid and protein 
acceptors (Kadowaki et al., 1996; Zhai et al., 2004; Yang et al., 2008).  The gene encoding 
DGAT2 was identified by its homology to a DGAT purified from the fungus Mortierella 
rammaniana (Cases et al., 2001; Lardizabal et al., 2001).  DGAT2 belongs to a seven-member 
gene family including monoacylglycerol acyl-CoA acyltransferase-1, -2 and -3 and wax 
synthases (Cases et al., 2001; Yen et al., 2002; Cao et al., 2003; Cheng et al., 2003; Yen et al., 
2003; Turkish et al., 2005) (Figure 2.3).  
 
 
 
  
 
Figure 2.2 DGAT Catalyzed Reaction. 
DGAT enzymes catalyze the formation of an ester linkage between a fatty acyl-CoA and the 
free hydroxyl group of diacylglycerol, generating triacylglycerol.  The diagram is modified 
from Yen et al. (2008). 
DGAT 
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Figure 2.3 Dendrograms of the DGAT Gene Families.  
The ACAT/DGAT1 gene family belongs to a superfamily of membrane-bound O-
acyltransferases (MBOAT).  Selected members are human enzymes unless indicated.  
MBOAT1 and MBOAT2 are members whose activities are unknown.  DGAT2 belongs to a 
seven-member gene family including monoacylglycerol acyl-CoA acyltransferase (MGAT)-1, -
2 and -3 and wax synthases.  DGAT candidate 3 (DC3) refers to a family member whose 
activity is unknown.  The diagrams are taken from Yen et al. (2008). 
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2.4 Structural and Functional Aspects of DGAT Enzymes 
Due to the difficulties in purifying DGAT enzymes to homogeneity, little is known 
about the molecular aspects of their structures and functions.  Murine and human Dgat1 genes 
encode a protein that is ~500 amino acids in length and shares 15-25% sequence identity, 
mostly in the C-termini, with ACAT enzymes (Cases et al., 1998).  A highly conserved motif 
present in DGAT1 and ACAT enzymes (FYXDWWN; amino acids 371–377 of murine  
DGAT1) has been implicated in binding the substrate fatty acyl-CoA.  Mutagenesis of this 
conserved domain in ACAT1 resulted in decreased enzymatic activity and affinity for acyl-
CoA (Guo et al., 2001).  However, there is no experimental evidence demonstrating the 
involvement of this domain in substrate binding for DGAT1.  In contrast, two independent 
studies indicated that the fatty acyl-CoA binding site may lie at the N-terminus of DGAT1, 
since a fragment containing approximately the first 100 amino acids of DGAT1 from the plant 
Brassica napus and mouse directly bind fatty acyl-CoA (Weselake et al., 2006; Siloto et al., 
2008).  Toward the C-terminal region, DGAT1 has a putative diacylglycerol-binding motif that 
is highly conserved across species and also present in various protein kinase C isoforms 
(Timmers et al., 2008; Talharia et al., 2009).  Protein kinase C binds to diacylglycerol through 
this motif.  DGAT1 is speculated to utilize this domain to interact with one of its substrates, 
diacylglycerol.  However, experimental evidence demonstrating the involvement of this domain 
in diacylglycerol binding is lacking.  
Recently, McFie et al. (2010) mapped the membrane topology of murine DGAT1 and 
demonstrated that it has three transmembrane domains with the N-terminus exposed to the 
cytosol.  The C- terminal region of DGAT1, which accounts for approximately 50% of the 
protein, was shown to be present in the ER lumen.  A highly conserved histidine residue (H426 
for murine DGAT1) in DGAT1 and ACAT enzymes, which McFie’s model suggested is 
present in the ER lumen, was determined to comprise part of the active site of DGAT1.  
Mutagenesis of H426 to alanine resulted in the complete loss of enzymatic activity of DGAT1.  
Despite the sequence homology between DGAT1 and ACAT enzymes, the putative active 
histidine residues in ACAT1 (H460) and ACAT2 (H434) were suggested to be partially 
imbedded within the cytoplasmic side of the lipid bilayer (Lin et al., 2003). 
Like ACAT enzymes, DGAT1 exists as a homotetramer (Cheng et al., 2001), and the N-
terminal domain of each subunit may be responsible for regulating dimer/tetramer formation
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(Cheng et al., 2001; McFie et al., 2010). 
Murine and human Dgat2 genes encode a protein that is ~350-400 amino acids in length 
and shares 40–45% sequence identity with its family members throughout the entire lengths of 
the proteins (Cases et al., 2001; Lardizabal et al., 2001).  The highly conserved sequence, 
“HPHG”, is present in all DGAT2 family members and is likely part of the active site of 
DGAT2 (Stone et al., 2006).  Mutagenesis of this sequence in murine DGAT2 resulted in 
significant reduction of in vitro DGAT activity.  Additionally, DGAT2 contains a consensus 
sequence (FLXLXXXn, where Xn is a nonpolar amino acid) for a putative neutral lipid binding 
domain that is present in proteins that bind to or metabolize neutral lipids (Stone et al., 2006).  
DGAT2 may utilize this domain to bind diacylglycerol.  Mutations in this region of murine 
DGAT2 also markedly reduced in vitro DGAT activity.  Stone et al also demonstrated that 
DGAT2 is an integral membrane protein with two transmembrane domains and that both the N- 
and C- termini are exposed to the cytosol. 
 
 
2.5 Enzymology and Cellular Biology of DGAT Enzymes 
Although both DGAT1 and DGAT2 have broad substrate specificities and utilize the 
same long-chain fatty acyl-CoAs (Cases et al., 2001), DGAT1, but not DGAT2, possesses 
additional acyltransferase activities in vitro (Yen et al., 2005).  DGAT1 is a potent acyl-CoA: 
retinol acyltransferase (ARAT), which catalyzes the synthesis of retinyl esters from retinol and 
fatty acyl-CoA substrates.  Several studies further suggest that DGAT1 may function as an 
ARAT in vivo, especially when the intracellular concentration of unesterified retinols is high 
(Yen et al., 2005; Wongsiriroj et al., 2008; Yamaguchi et al., 2008).  In addition, DGAT1 
exhibits in vitro acyl-CoA:monoacylglycerol acyltransferase activity, which catalyzes the 
esterification of monoacylglycerol with a fatty acyl-CoA to produce diacylglycerol (Yen et al., 
2005). The importance of the MGAT activity for DGAT1 function has not been determined.   
DGAT1 also displays in vitro activity of wax monoester and wax diester synthases, which 
catalyze the synthesis of wax esters from fatty alcohols and fatty acyl-CoAs (Yen et al., 2005).   
On the other hand, DGAT2 overexpression in rat hepatoma cells resulted in 
substantially higher triacylglycerol accumulation than DGAT1 overexpression did, with 
considerably larger lipid droplets (Stone et al., 2004).  These findings are consistent with 
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findings of the two enzymes in yeast.  Dga1, the yeast homologue of DGAT2, contributes 
predominantly to triacylglycerol synthesis and storage in yeast (Oelkers et al., 2002; Stone et 
al., 2004).  In contrast, the DGAT1 homologues in yeast, Are1 and Are2, serve primarily as 
sterol esterification enzymes (Yang et al., 1996) and play only a minor role in triacylglycerol 
synthesis (Oelkers et al., 2002; Stone et al., 2004).  
Studies of microsomes from rat adipocytes or livers revealed that DGAT activity 
(DGAT1 and DGAT2) was present in the ER (Wilgram et al., 1963; Coleman et al., 1976; 
Andersson et al., 1994; Rusinol et al., 1994; Lehner et al., 1996).   Studies using tobacco plant 
cells overexpressing tung tree DGAT1 and DGAT2 pinpointed them to distinct, non-
overlapping regions of the ER, suggesting different subcellular localization of DGAT1 and 
DGAT2 (Shockey et al., 2006).   
Recently, DGAT2, but not DGAT1 has been shown to associate with lipid droplets 
(Kuerschner et al, 2008; Stone et al., 2009).  DGAT2 may be directly embedded on the surface 
of lipid droplets and makes them another site for triacylglycerol synthesis.  Murine DGAT2 has 
a long hydrophobic region spanning amino acids 66-115 that comprises either a single extended 
transmembrane domain or two transmembrane domains (Stone et al., 2006).  The former 
conformation could allow the enzyme to bind directly to the lipid droplet surface (Stone et al., 
2009).  Indeed, a fraction of DGAT2 overexpressed in COS-7 cells co-purified with lipid 
droplets and was not due to ER contamination (Kuerschner et al., 2008).  Other studies have 
provided additional evidence for DGAT2 being localized to lipid droplets.  DGAT2 in the 
fungus Mortierella ramanniana was purified from the lipid body fraction (Lardizabal et al., 
2001), and Dga1 activity in yeast is enriched in lipid droplet fractions (Sorger et al., 2002).  A 
more likely explanation is that DGAT2 is present in the ER bilayer and is in close proximity to 
the lipid droplets (Stone et al., 2009).  Various proteomic analyses of isolated lipid droplets did 
not identify DGAT2 as a droplet component (Wu et al., 2000; Basaemle et al., 2004; Fujimoto 
et al., 2004; Liu et al., 2004; Umlauf et al., 2004; Beller et al., 2006; Cermelli et al., 2006; Sato 
et al., 2006; Turro et al., 2006; Wan et al., 2007).  Despite the uncertainty of the exact 
localization of DGAT2, the association of DGAT2 with lipid droplets corroborates the 
dedicated role of DGAT2 in bulk triacylglycerol synthesis and storage, while the ER-resident 
DGAT1 may be more important for synthesis of triacylglycerols destined for secretion 
(Kuerschner et al., 2008).  This is consistent with previous findings in McArdle RH7777 cells 
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showing that overexpression of DGAT1 did not lead to a significant increase in intracellular 
triacylglycerol level, while DGAT2 overexpression resulted in formation of large cytosolic 
lipid droplets (Stone et al., 2004).   
The membrane topology of DGAT2 suggests that the active site of DGAT2 resides on 
the cytosolic side of the ER, therefore, contributes only to the overt (cytosolic) activity (Stone 
et al., 2006), which synthesizes triacylglycerols destined for deposition into cytosolic lipid 
droplets (Waterman et al., 2002).  In contrast, DGAT1 accounts for both overt and latent 
(luminal) activities (Stone et al., 2006; Yen et al., 2008), the latter of which may contribute to 
synthesis of triacylglycerols for incorporation into lipoproteins and secretion into the circulation 
(Waterman et al., 2002).  The topology of DGAT1 indicates that the active site of DGAT1 is 
present in the ER lumen (McFie et al., 2010), suggesting a role for DGAT1 in lipoprotein 
assembly and secretion.  In support of this, overexpression of DGAT1 in rat hepatoma McArdle 
RH7777 cells stimulated VLDL secretion (Liang et al., 2004).  Additionally, overexpression of 
DGAT1 in mice resulted in increased latent DGAT activity in liver microsomes, which in turn 
caused a corresponding increase in the rate of VLDL secretion (Yamazaki et al., 2005).  
In addition to its association with the ER and lipid droplets, DGAT2 also interacts with 
mitochondria (Stone et al., 2009).  Immunofluorescence studies demonstrated that DGAT2 co-
localizes with mitochondria, and biochemical fractionation revealed the abundant presence of 
DGAT2 in mitochondria-associated membranes (MAM), specialized domains of the ER that 
co-isolate and physically interact with mitochondria.  MAM is enriched in activities of lipid 
biosynthetic enzymes, such as ACAT, DGAT, and phosphatidylserine synthase-1 and -2 (Cui et 
al., 1993; Rusinol et al., 1994; Stone et al., 2009).  A mitochondrial targeting signal was 
identified in murine DGAT2 between amino acids 61 and 66.  It is presumed that instead of 
being present directly in mitochondrial membranes, DGAT2 may be present in the MAM 
compartment and interact with mitochondria via its mitochondrial targeting sequence. It is 
unlikely that DGAT2 is present at the mitochondria membrane as DGAT2 has not been found 
in the mitochondrial proteomes from human and mouse tissues (Mootha et al., 2003; Taylor et 
al., 2003; Johnson et al., 2007).  Although DGAT1 does not associate with mitochondria, it is 
also present in MAM (Stone et al., unpublished observations), which sediments with 
mitochondria (at 10,000 x g) (Vance, 1989).  Mitochondria and MAM together are referred to 
as the crude mitochondrial fraction.   
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The reason for the interaction of DGAT2 with mitochondria is not clear.  This 
arrangement may promote the transfer of energy and exchange of substrates for triacylglycerol 
synthesis (Stone et al., 2009), because energy for activating fatty acids comes from 
mitochondria, and many enzymes that catalyze triacylglycerol formation are located in both 
mitochondria and ER (Coleman et al., 2000, 2004; Stone et al., 2009).    
 
 
2.6 Physiological Functions of DGAT Enzymes 
Our understanding of the physiological functions of DGAT enzymes in triacylglycerol 
metabolism stems largely from gene targeting studies in mice, which in turn reveal how the two 
DGAT enzymes serve fundamentally different roles in mammalian energy metabolism (Smith 
et al., 2000; Chen et al., 2002a; Stone et al., 2004).  Both DGAT1 and DGAT2 are ubiquitously 
expressed, with the highest levels of expression found in tissues that are active in 
triacylglycerol synthesis, such as white adipose tissue, liver, small intestine, and mammary 
gland (Yu et al., 2004; Yen et al., 2008).  Consequently, beyond their roles in systemic energy 
metabolism, DGAT enzymes also have been hypothesized to have a tissue-specific function in 
several physiologic processes in these tissues. 
 
2.6.1 Functions of DGAT Enzymes in Lipid and Energy Metabolism In vivo  
Targeted disruption of Dgat1 produced mice that are viable and have less adipose mass 
(~50% reduction).  DGAT1-deficient (Dgat1–/–) mice are leaner than wild-type mice and are 
resistant to diet-induced obesity through a mechanism involving increased energy expenditure 
(Smith et al., 2000).  Although the mechanism is not entirely clear, several factors have been 
suggested to play a role.  Dgat1–/– mice exhibited increased physical activity (Smith et al., 2000; 
Chen et al., 2002a) and thermogenesis (Chen et al., 2003), the latter may be attributable to the 
increased expression of uncoupling protein 1, a major mediator of nonshivering thermogenesis.  
Furthermore, increased sensitivity to leptin, an adipocyte-derived hormone that enhances 
energy expenditure, was observed in Dgat1–/– mice (Chen et al., 2002a).  Triacylglycerol levels 
in nonadipose tissues such as liver and skeletal muscle were moderately reduced in Dgat1–/– 
mice and plasma triacylglycerol levels were normal (Smith et al., 2000).  Dgat1–/– mice also 
had improved glucose tolerance as they have increased insulin sensitivity (Chen et al., 2002a; 
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Chen et al., 2003).  Adult Dgat1–/– mice appeared to have dry fur and hair loss, which may be 
associated with DGAT1’s pleiotropic acyltransferase activities (Yen et al., 2008).  Since wax 
diesters are a major species of fur lipids in rodents, the abolished wax diester synthase activity 
of DGAT1 may underlie the missing fur lipids in Dgat1–/– mice (Chen et al., 2002b).  Certain 
retinyl esters have been shown to promote hair growth (Bazzano et al., 1993).  Therefore, 
disrupted ARAT activity of DGAT1 may result in decreased production of retinyl esters, which 
in turn may lead to the abnormal development of hair in Dgat1–/– mice.  
Unlike DGAT1, DGAT2 is essential for life.  DGAT2-deficient (Dgat2–/–) mice die in 
the early postnatal period, with newborn pups surviving only 6-8 hours after birth (Stone et al., 
2004).  At least two mechanisms contribute to their early mortality.  One mechanism is the 
marked reduction in substrates for energy metabolism.  The carcass triacylglycerol content of 
Dgat2–/– mice was reduced by ~90%, and triacylglycerols were nearly undetectable in Dgat2–/– 
livers.  The plasma levels of triacylglycerols, free fatty acids, and glucose were reduced by 70-
90%.  Dgat2–/– mice also exhibited severe skin abnormalities with increased transepidermal 
water loss, which led to rapid dehydration and postnatal lethality.  The skin abnormalities were 
attributable to the deficiency of an essential fatty acid, linoleic acid in Dgat2–/– mice.  Linoleic 
acid is required for the synthesis of acylceramide, which is required for maintaining the 
permeability barrier of the skin.  
 
2.6.2 Functions of DGAT Enzymes in Adipose Tissue 
Adipose tissue is the predominant energy storage depot in the body, and DGAT 
enzymes are believed to play an important role in triacylglycerol synthesis for energy storage 
(Yu et al., 2004; Yen et al., 2008).  High levels of DGAT activity have been found in isolated 
rat adipocytes (Coleman et al., 1976) and in differentiated 3T3-L1 adipocytes (Coleman et al., 
1978; Cases et al., 1998; Cases et al., 2001).  
In addition to its synthetic function for energy storage, DGAT1 may also attenuate the 
deleterious effects of excessive fatty acids and their metabolites in non-adipose tissues by 
incorporating them into innocuous triacylglycerols in adipose tissue.  For example, 
overexpression of DGAT1 in white adipose tissue may protect against lipotoxicity in non-
adipose tissues (Chen et al., 2002c).  In response to a high-fat diet, aP2-Dgat1 transgenic mice 
(C57BL/6 genetic background) overexpressing DGAT1 in white adipose tissue had increased 
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triacylglycerol deposition in white adipose tissue and became more obese than wild-type mice.  
However, triacylglycerol levels were normal in non-adipose tissues in association with normal 
glucose metabolism.  In contrast, when fed a high-fat diet, no increased triacylglycerol content 
in white adipose tissue or obesity was observed in another line of aP2-Dgat1 transgenic mice 
(FVB genetic background) overexpressing DGAT1.  Consequently, these mice developed 
hyperglycemia, hyperinsulinemia, and hepatic steatosis in association with dramatically 
elevated plasma free fatty acid levels (Chen et al., 2005). 
 
2.6.3 Functions of DGAT Enzymes in Lipoprotein Metabolism 
 
2.6.3.1 Functions of DGAT Enzymes in the Intestine 
Dietary triacylglycerols cannot be absorbed intact.  In the intestine, the absorption of 
dietary triacylglycerols involves their initial hydrolysis in the intestinal lumen to free fatty acids 
and monoacylglycerol, which can cross from the gut to intestinal epithelial cells, subsequent re-
synthesis in enterocytes, and final incorporation of newly synthesized triacylglycerols into 
nascent chylomicrons for secretion into the circulation (Yu et al., 2004).  Although DGAT1 is 
highly expressed in the intestine, it appears to be non-essential for dietary triacylglycerol 
absorption and chylomicron assembly.  Dgat1–/– enterocytes can still synthesize triacylglycerol-
rich, chylomicron-sized particles (Buhman et al., 2002; Yu et al., 2004).  However, post-
absorptive plasma chylomicron levels were reduced in Dgat1–/– mice after a high-fat diet 
challenge, and lipid droplets accumulated in Dgat1–/– enterocytes when the mice were 
chronically fed a high fat diet.  All these results suggest that Dgat1–/– mice process dietary 
triacylglycerols through enterocytes into circulation at a decreased but more sustained rate, but 
the precise role of DGAT1 in this process remains unknown.  
In the intestine, DGAT2 expression was observed in mice, but was very low in humans 
(Cases et al., 2001).  Because there are no adult Dgat2–/– mice (Stone et al., 2004), no data can 
be obtained regarding the role of DGAT2 in dietary triacylglycerol absorption in the intestine. 
 
2.6.3.2 Functions of DGAT Enzymes in the Liver 
In the liver, DGAT enzymes are actively involved in the production of triacylglycerols, 
which may be channeled into cytosolic lipid droplets or be incorporated into nascent 
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apolipoprotein-B (apoB)-containing, triacylglycerol-rich, very low density lipoproteins (VLDL).  
Therefore, DGAT enzymes are believed to have a significant impact on the assembly and 
secretion of VLDL.  Overexpression of human DGAT1 in rat hepatoma McArdle RH7777 cells 
resulted in increased synthesis of triacylglycerols, decreased apoB degradation, and 
subsequently, enhanced secretion of triacylglycerols in the form of VLDL (Liang et al., 2004).  
In two separate in vivo studies, overexpression of DGAT1 in mouse liver via adenovirus 
increased cytosolic triacylglycerol levels in hepatocytes (Yamazaki et al., 2005; Millar et al., 
2006).  However, only one group observed an increase in triacylglycerol secretion (Yamazaki et 
al., 2005).  In both studies, overexpression of DGAT2 increased hepatic triacylglycerol levels, 
without augmenting VLDL secretion (Yamazaki et al., 2005; Millar et al., 2006).  However, 
knockdown of DGAT2 in the mouse liver with antisense oligonucleotide lowered the rate of 
hepatic triacylglycerol secretion and plasma triacylglycerol levels (Yu et al., 2005; Liu et al., 
2008).  Thus, the existing data suggest that DGAT1 has more of a role in VLDL production in 
the liver than DGAT2.  
 
2.6.4 Functions of DGAT Enzymes in Mammary Gland 
DGAT1 appears to be required for the development of the mammary gland in mice (Smith et 
al., 2000).  Instead of producing milk low in fat, female Dgat1–/– mice failed to lactate 
completely.  Neutral lipid-staining droplets were nearly absent in the apical regions of epithelial 
cells and in the ductal lumens of mammary glands from Dgat1–/– females.  DGAT1 deficiency 
is believed to cause impaired mammary epithelial proliferation and functional differentiation, 
which in turn result in impaired mammary gland development (Cases et al., 2004).   
 
 
 
2.7 Regulation of DGAT Enzymes 
Although gene targeting studies have shed light on their metabolic functions, very little 
is known about the mechanisms responsible for regulating DGAT enzymes.  Since DGAT 
enzymes function at a branch point in the glycerolipid biosynthetic pathway, one might expect 
these enzymes to be regulated as the diacylglycerol used by DGAT for triacylglycerol synthesis 
could potentially be used for phospholipid biosynthesis.  Previous studies have demonstrated 
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that DGAT enzymes may divert the flux of diacylglycerol from phospholipid synthesis toward 
triacylglycerol synthesis (Bagnato et al., 2003).   
In mice, DGAT2 mRNA expression appears to be much more sensitive to dietary 
conditions than DGAT1 (Meegalla et al., 2002).  DGAT2 mRNA levels were reduced in white 
adipose tissue and liver upon a 24 hour fast, and increased with refeeding.  In contrast, DGAT1 
did not exhibit such a pattern of change of mRNA levels.  These findings suggest that DGAT1 
might instead be regulated by post-transcriptional mechanisms rather than by changes in gene 
expression.  In addition, in both 3T3-L1 fibroblasts and adipocytes, overexpression of DGAT1 
by a recombinant adenovirus construct led to a 20-fold increase in DGAT1 mRNA levels (Yu et 
al., 2002a).  However, nearly no increase in DGAT activity was observed in fibroblasts and 
only a 2 fold increase was present in adipocytes, corroborating the possibility of extensive 
posttranscriptional regulation of DGAT1.     
Early studies in rat hepatocytes and white adipose tissue have provided evidence 
indicating that in vitro DGAT activity could be regulated post-transcriptionally via a 
phosphorylation-dephosphorylation mechanism.  DGAT activity appeared to be lower in rat 
liver microsomes isolated in the presence of 50 mM fluoride, a phosphatase inhibitor, than in 
control microsomes isolated without fluoride (Haagsman et al., 1981).  Furthermore, DGAT 
activity in both rat hepatocytes and white adipose tissue could be inactivated by a cytosolic 
factor in the presence of ATP and magnesium, conditions promoting protein phosphorylation 
(Haagsman et al., 1982; Rodriguez et al., 1992).  The inactivated DGAT could be reactivated 
by incubation with partially purified protein phosphatase(s) from rat liver, and inactivated again 
with further addition of ATP and magnesium in the presence of the cytosolic fraction.  These 
results suggest the existence of a protein kinase responsible for regulating DGAT activity.  
Partial purification of an inhibitory factor from adipose tissue suggested that it could be a 
tyrosine kinase, since it was inhibited by tyrosine kinase inhibitors and was insensitive to 
serine/threonine kinase inhibitors (Lau et al., 1996).  Both human and mouse DGAT1, but not 
DGAT2, contain a single conserved sequence for tyrosine phosphorylation (Oelkers et al., 1998; 
Cases et al., 2001).  However, when this site was mutated in human DGAT1 and expressed in 
3T3-L1 adipocytes, no significant effect on in vitro DGAT activity or overall cellular 
triacylglycerol accumulation was observed (Yu et al., 2002a).  Therefore, it appears unlikely 
that tyrosine phosphorylation at this site regulates DGAT1 activity.  However, the authors of 
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this study did not determine if the DGAT activity of the tyrosine mutant could still be inhibited 
with cytosol in the presence of ATP and magnesium. 
There has been some confusion with respect to regulation of DGAT activity by 
phosphorylation as different laboratories have published conflicting results regarding regulation 
by 3'-5'-cyclic adenosine monophosphate (cAMP).  Incubation of isolated rat hepatocytes with 
cAMP decreased their DGAT activity, suggesting regulation by cAMP-dependent pathways 
involving PKA (Haagsman et al., 1981; Lehner et al., 1996).  However, in another study in rat 
adipose tissue, the inhibitory effect of cAMP on DGAT activity was not observed, indicating 
that some other kinases other than PKA may be involved in the regulation of DGAT (Rodriguez 
et al., 1992; Lehner et al., 1996).  More interestingly, stimulatory effect of cAMP on DGAT 
activity was observed in hamster fibroblasts incubated with cAMP (Mazière et al., 1986; 
Lehner et al., 1996).  Most of these earlier studies are difficult to interpret since we now know 
there are two DGAT enzymes, both of which contain several putative phosphorylation sites, 
and therefore, these previous studies would not distinguish which DGAT was particularly 
modified in particular experiments. DGAT1, but not DGAT2, has the consensus sequence for 
two PKA phosphorylation sites (T15 and S244), suggesting that DGAT1 could be subject to 
regulation by cAMP-dependent pathways (Figure 2.4). 
 
 
2.8 Preliminary Data 
All preliminary experiments were performed by my supervisor, Dr. Scot Stone in the 
laboratory of Dr. R.V. Farese (Gladstone Institute of Cardiovascular Disease, San Francisco, 
CA).   
 
2.8.1 In vitro Phosphorylation of DGAT1 
To determine if DGAT1 and/or DGAT2 were subject to phosphorylation, rat hepatoma 
McArdle RH7777 cells overexpressing FLAG-tagged DGAT1 or DGAT2 were radiolabeled 
with [32P]inorganic phosphate.  After immunoprecipitation of DGAT1 and DGAT2 from the 
cells, phosphorylation was assessed by SDS-PAGE and autoradiography.  Only DGAT1, and 
not DGAT2, appeared to be phosphorylated (Figure 2.5).  Several bands labeled with [32P] 
inorganic phosphate were observed that corresponded to DGAT1, suggesting that DGAT1 may 
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have multiple phosphorylation sites.  The effect of phosphorylation on DGAT1 activity was 
then determined.  Microsomes and cytosol were prepared from McArdle RH7777 cells 
overexpressing DGAT1.  In vitro DGAT activity in microsomes was markedly inhibited by a 
cytosolic factor in the presence of magnesium and ATP (Figure 2.6).  When incubated with 
alkaline phosphatase, DGAT1 activity was increased ~5-fold, compared to the untreated control 
sample (Figure 2.7). 
 
 
 
 
 
 
Figure 2.4 Predicted Phosphorylation Sites of DGAT Enzymes for Various Kinases. 
DGAT1, but not DGAT2, has the consensus pattern [R/K](2)-X-[S/T] for PKA phosphorylation 
site at threonine-15 and serine-244.   
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Figure 2.5 DGAT1, but not DGAT2 is Phosphorylated.   
McArdle RH7777 cells overexpressing FLAG-tagged DGAT1 or DGAT2 were incubated with 
0.5 mCi [32Pi] for 4h.  DGAT1 and DGAT2 were then immunoprecipitated, separated by SDS 
PAGE and transferred to polyvinylidene difluoride membranes. Membranes were exposed to 
film to detect phosphorylation, followed by immunoblotting for DGAT1 and DGAT2 using a 
monoclonal anti-FLAG antibody.  McArdle RH7777 cells transfected with the expression 
vector lacking an insert were used as a control.  1x represents the monomer of DGAT1, 2x 
represents the dimer of DGAT1.  This experiment was carried out by Dr. Scot Stone. 
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Figure 2.6 Inactivation of DGAT1 under Conditions Promoting Protein Phosphorylation. 
Microsomes and cytosol were prepared from McArdle RH7777 cells overexpressing DGAT1. 
Microsomes were then pre-incubated under conditions outlined above, and DGAT activity was 
determined.  McArdle RH7777 cells transfected with the expression vector lacking an insert 
were used as a control.  TG: triacylglycerol.  This experiment was carried out by Dr. Scot 
Stone. 
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2.8.2 In vitro Phosphorylation of DGAT1 by PKA 
 Using a candidate kinase approach, PKA was identified as one possible kinase that 
could regulate DGAT1.  Partially purified DGAT1 was incubated with Mg2+, [γ32P]ATP, and 
either PKA, AMP-activated protein kinase (AMPK) or Casein kinase 2.  Phosphorylation was 
detected by SDS-PAGE and autoradiography.  A protein corresponding to DGAT1 was directly 
phosphorylated by PKA, and phosphorylation was prevented by a PKA inhibitor peptide, PKI 
(Figure 2.8).  AMPK and CK2 did not phosphorylate DGAT1.  In vitro DGAT activity in 
microsomes from McArdle RH7777 cells overexpressing DGAT1 was inhibited by PKA 
(Figure 2.9).  Furthermore, treatment of intact COS-7 cells with either forskolin or dibutyryl-
cAMP, two known PKA activators, inhibited in vitro DGAT activity by ~50% (Figure 2.10).   
This preliminary data strongly supports our hypothesis that DGAT1, and not DGAT2, is 
subject to regulation by phosphorylation/dephosphorylation and that PKA-dependant pathways 
are likely involved.   
 
 
 
        
Figure 2.7 Stimulation of DGAT1 under Conditions Promoting Protein 
Dephosphorylation. 
Microsomes were prepared from McArdle RH7777 cells overexpressing DGAT1.  Microsomes 
were then pre-incubated with or without alkaline phosphatase, and DGAT activity was 
determined. TG: triacylglycerol.  This experiment was carried out by Dr. Scot Stone. 
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2.9 Rationale and Objectives of the Proposed Research 
What is the biological significance of inhibiting DGAT1 activity by phosphorylation by 
PKA? I hypothesize that triacylglycerol synthesis and breakdown are coordinately regulated 
processes.  The role of PKA-dependent lipolytic pathways has been well studied.  In the fasted 
state, β-adrenergic stimulation of adipocytes activates adenylyl cyclase, thereby producing 
cAMP that activates PKA.  PKA phosphorylation of hormone sensitive lipase (HSL) and 
perilipin leads to subsequent activation and translocation of HSL to the lipid droplet, which in 
turn promotes hydrolysis of triacylglycerols (Souza et al., 2002; Sztalryd et al., 2003; Tansey et 
al., 2003; Zhang et al., 2003).  Additionally, PKA phosphorylation of perilipin activates 
adipose triacylglycerol lipase (ATGL), which is mediated through CGI-58, a protein activator 
of ATGL (Lass et al., 2006) that interacts with perilipin (Yamaguchi et al., 2004; Subramanian 
et al., 2004).  It was reported that phosphorylation of perilipin resulted in the dissociation of 
CGI-58 from perilipin, which in turn allowed CGI-58 to interact with ATGL and activate its 
lipase activity (Granneman et al., 2009).  
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Figure 2.8 In vitro Phosphorylation of DGAT1 by PKA.  
DGAT1 was partially purified from McArdle RH7777 cells overexpressing DGAT1 and 
incubated with Mg2+, [γ32P]ATP, and either PKA, casein kinase 2 (CK2) or AMP-activated 
protein kinase (AMPK).  Samples were separated by SDS-PAGE, transferred to polyvinylidene 
difluoride membrane and exposed to film to detect phosphorylation.  PKI is a PKA inhibitor.  
PKA underwent auto-phosphorylation.  McArdle RH7777 cells transfected with the expression 
vector lacking an insert were used as a control.  This experiment was carried out by Dr. Scot 
Stone. 
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Figure 2.9 Inhibition of In vitro DGAT Activity by PKA.  
Microsomes were isolated from McArdle RH7777 cells overexpressing DGAT1 and pre-
incubated with various units of PKA at room temperature for 30 min.  In vitro DGAT activity 
was then determined.  TG: triacylglycerol.  This experiment was carried out by Dr. Scot Stone. 
   
 
 
  
 
Figure 2.10 Inhibition of Endogenous DGAT Activity by PKA Activators.   
COS-7 cells were incubated with either 100 µM forskolin and 100 µM IBMX or 0.5 mM 
dibutyryl-cAMP for 20 min.  In vitro DGAT activity was then measured in cell lysates.  IBMX: 
isobutylmethylxanthine; TG: triacylglycerol.  This experiment was carried out by Dr. Scot 
Stone.   
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However, to our knowledge, what happens to the pathways of triacylglycerol synthesis 
in adipose tissue during lipolysis is not clear.  We hypothesize that during lipolysis, the rate of 
triacylglycerol synthesis in adipose tissue is decreased in order to promote the efficient net 
release of stored energy.  Under fasting conditions, phosphorylation of DGAT1 by PKA would 
inhibit its enzymatic activity, decreasing triacylglycerol synthesis.  In contrast, during the fed 
state, DGAT1 would be in a dephosphorylated and active form, promoting net triacylglycerol 
synthesis and storage.  I shall determine the significance of PKA phosphorylation in regulating 
DGAT1 and triacylglycerol synthesis.  
 
The specific objectives of this thesis were: 
1. Determining DGAT activity during lipolysis in 3T3-L1 adipocytes. 
2. Mapping PKA phosphorylation site(s) of DGAT1 and studying their functional importance. 
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3.0 MATERIALS AND METHODS 
 
 
3.1 Reagents 
Names of reagents and their suppliers are listed in Table 3.1.  Addresses of reagent 
suppliers are listed in Table 3.2.  Names of primer pairs used for site-directed mutagenesis of 
DGAT1 and their sequences are listed in Table 3.3.  
Table 3.1: List of Reagents and Suppliers 
General Reagent Supplier  
Anti-FLAG M2-Agarose Beads Sigma-Aldrich 
Bovine Serum Albumin-essentially fatty acid free Sigma-Aldrich 
Brilliant Blue R Sigma-Aldrich 
[14C]Oleoyl-CoA GE Healthcare 
Chlorophenylthio-Cyclic AMP Sigma-Aldrich 
Cycloheximide Sigma-Aldrich 
Diethyl-p-Nitrophenyl Phosphate Sigma-Aldrich 
1,2-Dioleoyl-sn-Glycerol Sigma-Aldrich 
Disuccinimidyl Suberate Pierce 
3X FLAG Peptide Sigma-Aldrich 
[3H]Glycerol (1mCi/mL) American Radiolabeled 
Chemicals, Inc.  
Polyethylenimine Polysciences 
Protease Inhibitor Tablet (Complete, Mini) Roche 
Protein Kinase A (catalytic subunit) Promega 
Oleic Acid Sigma-Aldrich 
Salmon Sperm DNA Sigma-Aldrich 
Bacterial Culture Reagent Supplier 
Ampicillin Bio Basic Inc. 
Tryptone  DIFCO 
Yeast Extract EMD 
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NZ-Amine A® from Bovine Milk  Sigma-Aldrich 
Mammalian Cell Culture Reagent Supplier 
Antibiotic-Antimyotic (100X)  Invitrogen 
Dulbecco's Modified Eagle's Medium – High Glucose        Lonza 
Dexamethasone Sigma-Aldrich 
Fetal Bovine Serum (Canadian Origin) PAA Laboratories Inc. 
Horse Serum Invitrogen 
Isobutylmethylxanthine Sigma-Aldrich 
Insulin (10mg/mL) Sigma-Aldrich 
Trypsin (0.05 %,1x, EDTA)  Invitrogen 
Yeast Culture Reagent Supplier 
Galactose  Acros Organics 
Raffinose     Sigma-Aldrich 
Yeast Nitrogen Base DIFCO 
 
Table 3.2 List of Names and Addresses of Reagent Suppliers 
Supplier Address 
Acros Organics Morris Plains, New Jersey, USA 
American Radiolabeled Chemicals, Inc. St. Louis, Missouri, USA  
Bio Basic Inc. Markham, Ontario, Canada 
Bio-Rad Hercules, California, USA 
Denville Scientific St. Laurent, Quebec, Canada 
DIFCO Sparks, Michigan, USA 
EMD Madison, Wisconsin, USA 
GE Healthcare Baie d’Urfe, Quebec, Canada 
Invitrogen Burlington, Ontario, Canada 
Lonza Walkersville, Maryland, USA 
Matrix Science London, UK 
PAA Laboratories Inc. Etobicoke, Ontario, Canada 
Pierce Rockford, Illinois, USA 
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Polysciences Warrington, Pennsylvania, USA 
Promega Madison, Wisconsin, USA 
Roche Mississauga, Ontario, Canada 
Sigma-Aldrich Oakville, Ontario, Canada 
Stratagene La Jolla, California, USA 
Whatman Piscataway, New Jersey, USA 
VWR Mississauga, Ontario, Canada 
 
Table 3.3: List of Primers (Invitrogen) for Site-directed Mutagenesis of DGAT1 
(modifications are underlined) 
Primer Name Primer Sequence 
S17A-F 5’-AGGACCGGCGCACGGGTTTCCGTCC-3’ 
S17A-R 5’-GGACGGAAACCCGTGCGCCGGTCCT-3’ 
S25A-F 5’-CGTCCAGGGTGGTGCTGGGCCCAAGGTAGAAG-3’ 
S25A-R 5’-CTTCTACCTTGGGCCCAGCACCACCCTGGACG-3’ 
S17/20/25A-F 5’-CGCACGGGTTGCCGTCCAGGGTGGTGCTGGGCCCAAGG-3’ 
S17/20/25A-R 5’-CCTTGGGCCCAGCACCACCCTGGACGGCAACCCGTGCG-3’ 
T15D-F 5’-CGGCGTCGGAGGGACGGCTCGCGGGTTTCC-3’ 
T15D-R 5’-GGAAACCCGCGAGCCGTCCCTCCGACGCCG-3’ 
S17D-F 5’-CGTCGGAGGACCGGCGACCGGGTTTCCGTCCAG-3’ 
S17D-R 5’-CTGGACGGAAACCCGGTCGCCGGTCCTCCGACG-3’ 
S20D-F 5’-GGCTCGCGGGTTGACGTCCAGGGTGGTAGT-3’ 
S20D-R 5’-ACTACCACCCTGGACGTCAACCCGCGAGCC-3’ 
S25D-F 5’-CGTCCAGGGTGGTGATGGGCCCAAGGTAGAAG-3’ 
S25D-R 5’-CTTCTACCTTGGGCCCATCACCACCCTGGACG-3’ 
S17/20/25D-F 5’-ACCGGCGACCGGGTTGACGTCCAGGGTGGTGATGGGCCC-3’ 
S17/20/25D-R 5’-GGGCCCATCACCACCCTGGACGTCAACCCGGTCGCCGGT-3’ 
S17/20/25A-F 
(yeast) 
5’-GACCGGCGCGCGGGTTGCCGTCCAGGGTGGTGCTGGGCCCA-3’ 
S17/20/25A-R  
(yeast) 
5’-TGGGCCCAGCACCACCCTGGACGGCAACCCGCGCGCCGGTC-3’ 
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3.2 Bacteria Strain, Yeast Strain and Media Preparations 
            E. coli DH5α competent cells (Invitrogen) were used as the host to propagate plasmids. 
XL10-Gold Ultracompetent E. coli cells (Stratagene) were used as the host to recover very low 
amounts of mutated plasmids during site-directed mutagenesis. 
Luria-Bertani (LB) and Terrific Broth (TB) liquid media were used to propagate 
bacterial cells.  LB was prepared by combining 10 g of tryptone, 5 g of yeast extract and 10 g of 
NaCl in 1 L of double distilled water.  TB was prepared by combining 12 g of tryptone, 24 g of 
yeast extract and 4 mL of glycerol in 900 mL of double distilled water.  Both solutions were 
sterilized by autoclaving for 20 min at 15 lb/sq. in.  After autoclaving, 100 mL of a sterile 
solution containing 0.17 M KH2PO4 and 0.72 M of K2HPO4 was added to TB.  Ampicillin was 
added to the medium to a final concentration of 50 µg/mL when required for the selection and 
propagation of bacteria with a vector containing an Ampicillin-resistant gene.  LB agar plates 
were made by adding 15 g of agar to 1 L of LB medium.  After autoclaving, the medium was 
cooled and mixed with ampicillin (final concentration of 50 µg/mL) and poured into petri 
dishes.  The LB agar plates were stored at 4 ºC until used. 
NZY+ broth used for the transformation of XL10-Gold ultracompetent cells was 
prepared by combining 10 g of NZ-amine, 5 g of yeast extract, and 5 g NaCl in 1 L of deionized 
water.  The solution was adjusted to pH 7.5 and sterilized by autoclaving as described above.  
Prior to use, NZY+ broth was supplemented with filter-sterilized 12.5 mM MgCl2, 12.5 mM 
MgSO4 and 0.004% (w/v) glucose. 
Yeast Strain Saccharomyces cerevisiae H1246MATα (Sandager et al., 2002) was used 
to express murine DGAT1 and various mutants. 
Synthetic complete medium lacking uracil (SC-Ura medium) was used to select and 
propagate yeast cells with a vector containing a gene for uracil synthesis.  SC-Ura medium was 
prepared by dissolving 6.7 g of yeast nitrogen base, 0.1 g of each of adenine, arginine, cysteine, 
leucine, lysine, threonine and tryptophan, 0.05 g of each of aspartic acid, histidine, isoleucine, 
methionine, phenylalanine, proline, serine, tyrosine and valine in 800 mL of deionized water.  
This mixture was autoclaved as described above.  Once cooled, 200 mL of filter-sterilized 10% 
raffinose was added to complete the SC-Ura medium.  SC-Ura agar plates were made by adding 
20 g of agar to 1 L of SC-Ura medium.  After autoclaving, the medium was cooled and poured 
into petri dishes.  The SC-Ura agar plates were stored at 4 ºC until used.  
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SC-Ura induction medium was used to induce the expression of wild-type DGAT1 and 
various mutants downstream of the GAL1 promoter inducible by galactose.  It was prepared as 
the SC-Ura medium with the exception that 100 ml of filter-sterilized 20% galactose and 100 
ml of filter-sterilized 10% raffinose were added to the 800 mL mixture to complete the medium.  
 
 
3.3 Mammalian Cell Culture 
3T3-L1 cells and McArdle RH7777 rat hepatoma cells stably expressing FLAG-tagged 
DGAT1 (Stone et al., 2004) were kindly provided by Dr. R.V. Farese (Gladstone Institute of 
Cardiovascular Disease, San Francisco, CA).  Human embryonic kidney 293T (HEK293T) cells 
were gifts from Dr. W. J. Roesler (University of Saskatchewan, Saskatoon, SK).  All cells were 
maintained at 37 ºC with 5% CO2.  McArdle RH 7777 cells were cultured in Dulbecco’s 
modified Eagle's medium (DMEM) with 10% fetal bovine serum (FBS) and 10% horse serum.  
3T3-L1 cells and HEK293T cells were maintained in DMEM with 10% FBS.  3T3-L1 
cells were induced to differentiate into adipocytes by incubating ~90% confluent pre-adipocytes 
in DMEM supplemented with 10% FBS, 10-5 M dexamethasone, 0.5 mM 
isobutylmethylxanthine, and 10 µg/mL insulin for 72 hr (Brasaemle et al., 1997).  Medium was 
changed every 24 hr.  72 hr post-induction, the differentiation medium was withdrawn and the 
cells were maintained in DMEM containing 10% FBS.  
 
 
3.4 Immunoaffinity Purification of DGAT1 
The protocol described refers to cells propagated in a 100 mm tissue culture plate.  All 
manipulations were performed at 4 °C.    
 
3.4.1 Subcellular Fractionation 
McArdle RH7777 cells stably expressing FLAG-tagged DGAT1 were washed twice 
with ice-cold phosphate-buffered saline (PBS), harvested by scraping, and collected by 
centrifugation at 1000 × g for 2 min.  The cell pellet was resuspended in 500 µL of ice-cold 
PBS containing 50 mM of phosphatase inhibitor, NaF and protease inhibitors.  Cells were lysed 
by 15 passages through a 27-gauge needle.  Cell debris and nuclei were pelleted by 
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centrifugation at 1000 × g for 2 min.  The supernatant was centrifuged at 16,000 × g for 10 min 
to pellet crude mitochondrial fraction that contains mitochondria and MAM (Stone et al., 2009).  
The 16,000 × g supernatant was subjected to centrifugation at 100,000 × g for 30 min to pellet 
microsomes.  Crude mitochondrial fraction and microsomes were combined and solubilized in 
400 µL of PBS containing 0.5% SDS and 0.5% Triton X-100 in the presence of phosphatase 
and protease inhibitors, which is referred to as the solubilization buffer from now on.    
 
3.4.2 Immunoprecipitation of DGAT1  
40 µL of anti-FLAG M2-agarose beads were washed twice with ice-cold PBS and 
incubated with the solubilized crude mitochondrial and microsomal fractions prepared from 
above at 4 °C for 2 hr (rotating).  Agarose beads were pelleted by centrifugation at 16,000 x g 
for 1 min, and washed 5 times with the solubilization buffer.  FLAG-tagged DGAT1 was eluted 
by incubating agarose beads with 30 µL of the solubilization buffer containing 3X FLAG 
peptide (final concentration of 0.5 µg/µL) at 4°C for 30 min (rotating).  Agarose beads were 
pelleted by centrifugation at 16,000 x g for 1 min and the supernatant containing partially 
purified DGAT1 was removed.   
 
3.4.3 Western Blot Analysis 
Immunoprecipitated samples (30 µL) were incubated with 5X SDS loading buffer (7.5 
µL)  (250 mM Tris-HCl, pH 6.8, 10% SDS, 50% glycerol, 1% bromophenol blue, and 25% β 
mercaptoethanol) at 37 ºC for 20 min, followed by separation by SDS-PAGE on a 10% 
polyacrylamide gel in the running buffer (25 mM Tris-HCl, 192 mM glycine, and 0.1 % (w/v) 
SDS) at 160 volts for 1 hr.  Samples were incubated at 37 ºC because DGAT1 protein is very 
hydrophobic (Stone et al., 2006) and forms aggregates at higher temperatures.  Proteins were 
transferred to a polyvinylidene difluoride membrane (Bio-Rad) at 350 mA for 2 hr in the 
transfer buffer consisting of 62.5 mM boric acid (pH 8.0).  The membrane was subsequently 
blocked in 5% milk at room temperature (RT) for 1 hr and probed overnight at 4 °C with a 
mouse monoclonal anti-FLAG-M2 antibody (Sigma-Aldrich, 1:5,000).  The membrane was 
then incubated with a goat-anti-mouse polyclonal antibody conjugated to horseradish 
peroxidase (Bio-Rad, 1:8,000) for 1 hr at RT.  The membrane bound antibody-protein 
complexes were detected using SuperSignal West Pico Chemiluminescent Substrate
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(Pierce) as described by the manufacturer and exposed to Hyblot Cl film (Denville Scientific). 
 
 
3.5 MS Analysis of DGAT1 
In order to obtain sufficient quantities of DGAT1 for MS analysis, DGAT1 was 
immunoprecipitated from ten 100 mm culture dishes of McArdle RH7777 cells stably 
expressing FLAG-tagged DGAT1 as described above.  Procedures were scaled up accordingly.  
The immunoprecipitates containing affinity purified DGAT1 were incubated with 100 units of 
the catalytic subunit of protein kinase A (PKA) in a final volume of 50 µL kinase buffer (50 
mM Tris-HCl, pH 7.5, 250 mM sucrose, 2.5 mM ATP, 5 mM MgCl2, 50 mM NaF) at 30 °C for 
30 min.  Following separation by SDS-PAGE, proteins were visualized by staining with a 
solution containing 0.2% (w/v) Brilliant blue R, 40% (v/v) methanol and 10% (v/v) acetic acid 
for 30 min, followed by destaining with 40% (v/v) methanol and 10% (v/v) acetic acid 
overnight.  The protein band corresponding to DGAT1 was excised from the gel.  PKA 
phosphorylation sites were then identified by analyzing multiple trypsin digests of affinity 
purified DGAT1 with high-performance liquid chromatography (HPLC)–electrospray 
ionization (ESI)-MS/MS, which is carried out by the MS facility of the NRC Plant 
Biotechnology Institute (Saskatoon, SK) on a fee-for-service basis.   
 
 
3.6 Site-directed Mutagenesis 
N-terminal FLAG-tagged murine DGAT1 in the eukaryotic expression vector 
pCDNA3.1 (Stone et al., 2004), or the cDNA encoding N-terminal FLAG-tagged DGAT1 
cloned into a yeast expression vector pYES2 (Invitrogen) (generated by Pam McFie and Greg 
Lutz in our laboratory), were used as templates for mutagenesis reactions.  The various 
mutations were introduced using the primer pairs listed in Table 3.3 and the QuikChange II XL 
site-directed mutagenesis kit (Stratagene).  The PCR mixture was set up as follows (in a total 
reaction volume of 50 µL): 50 ng of DNA, 5 µL of 10X reaction buffer, 0.2 mM dNTPs, 125 ng 
each of forward and reverse primers, 5 µL of dimethyl sulfoxide (DMSO), and 1 µL of PfuUltra 
High Fidelity DNA polymerase.  The thermal cycling parameters used for the PCR were as 
follows: initial denaturation at 95°C for 1 min, followed by 18 cycles at 95 °C for 50 sec, 60 °C 
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for 50 sec, and 68 °C for 6.5 min, with termination at 68 °C for 7 min.  Following PCR, the 
product was treated with DpnI endonuclease, and transformed into XL10-Gold ultracompetent 
cells as described by the manufacturer.  Plasmid DNA was isolated from transformants as 
described by Sambrook et al. (1989).  All constructs were sequenced to verify the presence of 
the intended mutations by the sequencing facility of the NRC Plant Biotechnology Institute 
(Saskatoon, SK).   
 
 
3.7 Expression of DGAT1  
 
3.7.1 Mammalian Cell Transfection 
For each transfection, 60 µL of 0.1% polyethylenimine was gently mixed with a mixture 
containing 20 µg of plasmid DNA and 430 µL of 150 mM NaCl in a 14 mL polypropylene tube 
at RT for 10 sec.  The transfection mixture was then incubated at RT for 10 min and added 
drop-wise to a 100 mm tissue culture plate containing HEK293T cells at 70% confluency.  
Cells were incubated at 37°C with 5% CO2 for 4 hr, and then re-fed with fresh culture medium.  
48 hr post-transfection, cells were harvested and used for experiments. 
 
3.7.2 Yeast Transformation 
For each transformation, 1 µg of plasmid DNA was added into a 14 mL polypropylene 
tube containing 100 µg of denatured salmon sperm DNA and 100 µL of competent yeast 
containing approximately 106 cells.  600 µL of PEG/LiAc solution (10 mM Tris-HCl, pH 7.5, 
40% PEG-3350 solution, 100 mM lithium acetate, 1 mM EDTA,) was added to the mixture, 
followed by brief vortexing.  The transformation mixture was then incubated at 30°C for 30 min 
with shaking at 250 rpm, and 70 µL of DMSO was added after the incubation.  Yeast cells were 
heat shocked at 42°C for 15 min and transferred to a 1.5 mL microcentrifuge tube.  Cells were 
collected by centrifugation at 16,000 x g for 15 sec.  The pellet was resuspended in 500 µL of 
1X TE buffer (10 mM Tris-HCl, pH 7.5, and 1 mM EDTA), and plated on SC-Ura agar plates 
to select transformants with a vector containing a gene for uracil synthesis.  A single colony 
was inoculated into 15 mL of SC-Ura medium and grown at 30 °C overnight.  The overnight 
culture was diluted to an OD600 of 0.4 in 50 mL of SC-Ura induction medium and grown at
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30 °C for 24 hr.  After induction, yeast were harvested and used for experiments.   
 
 
3.8 Measurement of In vitro DGAT Activity 
 
3.8.1 Extraction of Total Cellular Membranes 
All manipulations were performed at 4 °C.    
The protocol described refers to mammalian cells propagated in a 100 mm tissue culture 
plate.  Cells were washed twice with ice-cold PBS, harvested by scraping, and collected by 
centrifugation at 1000 x g for 2 min.  The cell pellet was resuspended in 500 µL of ice-cold 
lysis buffer (50 mM Tris-HCl, pH 7.4, 250 mM sucrose, and protease inhibitors), and passed 
through a 27-gauge needle 15 times to lyse cells.  Cell debris and nuclei were removed by 
centrifugation at 1000 x g for 2 min.  The supernatant was subjected to centrifugation at 
100,000 x g for 30 min to pellet total cellular membranes. The membrane pellet was 
resuspended in 200 µL of ice-cold lysis buffer.  In most experiments, 50 mM NaF was included 
in the lysis buffer to minimize dephosphorylation of DGAT1.  In some experiments, cells were 
pre-incubated with 0.5 mM chlorophenylthio-3'-5'-cyclic adenosine monophosphate (CPT-
cAMP) for 0-120 min before harvesting, to activate lipolysis.    
The protocol described refers to yeast cells propagated in 10 mL of induction medium.  
24 hr post-induction, yeast cells were collected by centrifugation at 1500 x g for 5 min.  The 
cell pellet was resuspended in 500 µL of sterile water and transferred to a microcentrifuge tube.  
Yeast were collected by centrifugation at 16,000 x g for 30 sec and resuspended in 500 µL of 
ice-cold breaking buffer (50 mM sodium phosphate, pH 7.4, 1 mM EDTA, 5% glycerol, 1 mM 
PMSF).  Yeast were then lysed by adding an equal volume of acid-washed glass beads (425-
600 µm size, Sigma-Aldrich), and bead beating the mixture 4 times for 1 min in a bead beater 
(VWR), with 1 min on ice in between beatings.  Cell debri, nuclei, and the beads were pelleted 
by centrifugation at 1000 x g for 5 min.  The supernatant was centrifuged at 100,000 x g for 30 
min to pellet total cellular membranes.  The membrane pellet was resuspended in 200 µL of ice-
cold 50mM Tris-HCl (pH 7.4) buffer containing 250 mM sucrose, 50 mM NaF and protease 
inhibitors. 
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3.8.2 Analysis of Protein Expression Levels 
The protein concentration of total cellular membrane extractions was determined using 
the Bio-Rad Protein Assay kit (Bio-Rad) as indicated by the manufacturer.  Protein samples 
were adjusted to a final concentration of 1 µg/µL.  Aliquots of protein samples were then 
subjected to western blot analysis as described in section 3.4.3.   
 
3.8.3 In vitro DGAT Activity Assay  
DGAT activity assays were carried out in 16 x 100 mm glass test tubes in a total volume 
of 200 µL.  In brief, these assays measured the incorporation of radiolabelled oleoyl-CoA into 
triacyglycerol in a 10 min assay using sn-1, 2-diacylglcyerol and [14C]oleoyl-CoA as substrates.  
A typical reaction contained 50-200 µg of protein in 100 µL of total cellular membrane 
extractions, which was added to 100 µL of assay mixture (200 mM Tris-HCl, pH 7.5, 40 mM 
MgCl2, 25 mg/mL bovine serum albumin (BSA)-essentially fatty acid free, 400 mM 1,2-
dioleoyl-sn-glycerol [in acetone, vehicle concentration 10% (v/v)], and 50 µM [14C]oleoyl-CoA 
at 18 µCi/µMol).  The reaction mixture was incubated at 37 ºC for 10 min, followed by 
termination of the reaction with 4 mL of chloroform: methanol (2:1, v/v).  800 µL of distilled 
water was then added, and the mixture was vortexed and incubated at RT for 1 hr.  After 
incubation, the mixture was centrifuged at 1000 x g for 5 min to separate the organic and 
aqueous phases.  The aqueous phase was removed by aspiration and the organic phase 
containing lipids was dried under air.  Dry lipids were resuspended in 75 µL of chloroform: 
methanol (2:1, v/v) and applied to a 20 x 20 cm Thin Layer Chromatography (TLC) plate 
(Whatman), which was developed in hexane: diethyl ether: acetic acid (80: 20: 1, v/v/v).  In 
vitro DGAT activity was determined by measuring the incorporation of radiolabelled [14C] 
oleoyl-CoA into triacylglycerol.  Triacylglycerol was visualized by staining lipids with iodine 
vapor.  The band corresponding to triacylglycerol was scraped off the plate, and quantified by 
scintillation counting as described by Taylor et al. (1991).  
In some experiments, in vitro DGAT activity assays were carried out with various 
concentrations 1,2-dioleoyl-sn-glycerol to establish a dioleoylglycerol substrate saturation curve 
of DGAT1.  
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3.9 Quantification of Triacylglycerol Synthesis 
48 hr post-transfection, HEK293T cells transiently expressing wild-type DGAT1 and 
various mutants were washed twice with PBS, and incubated for 6 hr with fresh culture medium 
containing 10 µCi [3H]glycerol and 0.375mM oleic acid complexed to 0.5% BSA.  Cells were 
then washed twice with ice-cold PBS, harvested by scraping, and collected by centrifugation at 
1000 x g for 2 min.  Cells were resuspended in 500 µL of ice-cold PBS and disrupted by 15 
passages through a 27-gauge needle.  Cell debris and nuclei were pelleted by centrifugation at 
1000 x g for 2 min.  Lipids were extracted from 200 µL of the total cell lysate, and separated by 
TLC as described in Section 3.8.3. Triacylglycerol synthesis was quantified by measuring the 
incorporation of radiolabelled [3H]glycerol into triacylglycerol.  Radioactivity of the 
triacylglycerol band was determined as described in Section 3.8.3.  
In some experiments, triacylglycerol levels were determined in non-radioactive lipid 
samples.  Lipids were visualized by charring the TLC plate at 180 ºC after immersion in a 
solution containing 10% cupric sulfate (w/v) and 8% phosphoric acid (v/v).  The intensity of 
triacylglycerol bands were quantified with ImageJ software. 
 
 
3.10 Cross-linking Studies 
Total cellular membranes were extracted from HEK293T cells transiently expressing 
wild-type DGAT1 and various mutants as described in Section 3.8.1 with the exception that the 
lysis buffer was 1X PBS containing protease inhibitors.  Membrane pellets were resuspended in 
200 µL of the lysis buffer, followed by incubation with various concentrations of 
disuccinimidyl suberate [in DMSO, vehicle concentration 2% (v/v)] at RT for 1 hr.  The 
reactions were terminated with 1/10 volume of 1M Tris-HCl (pH 8.0).  Protein samples were 
then separated by SDS-PAGE and immunoblotted for DGAT1 as described in Section 3.4.3.  
 
 
3.11 Determination of Protein Stability 
To block protein synthesis, HEK293T cells transiently expressing wild-type DGAT1 
and various mutants were washed twice with PBS and incubated with fresh culture medium 
containing 100 µg/mL cycloheximide for 0-12 hr.  Cells were harvested at different time points, 
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followed by extracting total cell lysates as described in Section 3.9.  Turnover rate of wild-type 
DGAT1 and the mutants was determined by Western blot analysis as described in Section 3.4.3.    
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4.0 RESULTS 
 
 
4.1 The Role of PKA in Regulating DGAT Activity and Triacylglycerol Synthesis 
During Lipolysis 
Lipolysis is a process by which stored triacylglycerols in white adipose tissue are 
hydrolyzed to fatty acids and glycerol when blood glucose level decreases.  Fatty acids enter the 
circulation and go to peripheral organs and tissues, where they are oxidized to produce large 
quantities of ATP.  Since lipolysis serves to break down stored triacylglycerols, we investigated 
what would happen to the triacylglycerol biosynthetic pathway during lipolysis, expecting that 
triacylglycerol synthesis would be inhibited to promote the efficient net release of stored 
energy.  To test this, we examined DGAT activity during lipolysis in 3T3-L1 adipocytes.  
3T3-L1 pre-adipocytes were cultured and differentiated into adipocytes.  On day 10 of 
differentiation, large cytoplasmic lipid droplets were visible.  Lipolysis was stimulated by 
incubating adipocytes with CPT-cAMP, which is a non-hydrolysable cell permeable cAMP 
analogue that activates PKA.  As described in Section 2.9, PKA phosphorylates HSL and 
perilipin, leading to subsequent activation of HSL and ATGL.  It was observed that 
triacylglycerol levels decreased as the incubation time of adipocytes with CPT-cAMP 
increased, confirming the activation of lipolytic pathways by CPT-cAMP (Figure 4.1).  
To examine the role of PKA in regulating DGAT activity in adipose tissue during 
lipolysis, in vitro DGAT activity in total cellular membranes was measured.  Total cellular 
membranes from adipocytes treated with 0.5 mM CPT-cAMP were pre-incubated with 100 µM 
of lipase inhibitor, diethyl-p-nitrophenyl phosphate, to minimize degradation of [14C] 
triacylglycerol formed during the DGAT assay, and assayed for in vitro DGAT activity.  
Unexpectedly, DGAT activity showed an approximately two-fold increase during lipolysis in 
adipocytes (Figure 4.2), which is opposite to our hypothesis, and also contradicts the previous 
findings showing that in vitro DGAT activity in McArdle RH7777 rat hepatoma cells 
overexpressing DGAT1 was inhibited by PKA.    
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Figure 4.1 Activation of Lipolysis by CPT-cAMP.   
3T3-L1 adipocytes were harvested at the indicated incubation times with 0.5 mM CPT-cAMP.  
Lipids were extracted from total cell lysates and separated by TLC.  Lipids were visualized by 
charring the TLC plate after immersion in cupric sulfate/phosphoric acid.  This is a 
representative result from three independent experiments. 
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Figure 4.2 Stimulation of DGAT Activity during Lipolysis in Adipocytes.   
In vitro DGAT activity assays were performed by measuring activity of 50 µg of protein from 
total cellular membranes extracted from 3T3-L1 adipocytes incubated with CPT-cAMP for 0-
120 min.  Pre-adipocytes were used as a control.  Data are mean + S.D. for triplicate analyses 
from one experiment, which was repeated twice with similar results.  TG: triacylglycerol.  
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4.2 Mapping the PKA Phosphorylation Site(s) of DGAT1 by Mass Spectrometry 
 
4.2.1 Optimized Immunopurification of DGAT1 
As stated in Figure 2.4, DGAT1 has the consensus pattern ([R/K](2)-X-[S/T]) for PKA 
at threonine-15 and serine-244.  Using site-directed mutagenesis, Stone et al. (unpublished 
observations) previously attempted to map which of these potential sites were phosphorylated 
by PKA.  However, DGAT1 mutants with these residues mutated to alanine residues were still 
phosphorylated by PKA.  Other serine and threonine residues that were considered to be 
“weak” PKA sites were also mutated.  These additional mutants were also still phosphorylated 
by PKA.  Since the results from previous site-directed mutagenesis studies were inconclusive, 
we decided to use MS to map potential PKA phosphorylation sites in an unbiased manner.  
To determine phosphorylation sites within DGAT1 by MS, murine DGAT1 was affinity 
purified from McArdle RH7777 rat hepatoma cells that stably express FLAG-tagged DGAT1.  
Although DGAT1 is a hydrophobic membrane protein that has never been purified to 
homogeneity (Cases et al., 1998), Stone et al. (unpublished observations) have recently 
optimized the conditions that allow us to partially purify DGAT1 in an active state from 
McArdle RH7777 rat hepatoma cells.  FLAG-tagged DGAT1 was initially immunoprecipitated 
from total cell lysate with anti-FLAG agarose beads and eluted with an excess of free FLAG 
peptide.  Prior to incubation with anti-FLAG agarose beads, total cell lysate was solubilized 
with PBS containing 1% SDS in the presence of phosphatase and protease inhibitors.  The 
immunoprecipitates containing partially purified DGAT1 were separated by SDS-PAGE and 
immunoblotted for DGAT1.  Only a small amount of DGAT1 protein was detected in the 
starting material after incubation with the anti-FLAG antibody, while the majority of DGAT1 
had been successfully immunoprecipitated (Figure 4.3A).  Subsequently, to obtain sufficient 
quantities of DGAT1 for MS analysis, DGAT1 was immunoprecipitated from total cell lysate 
of 10 100 mm dishes of McArdle RH7777 cells stably expressing FLAG-tagged DGAT1.  
Following separation by SDS-PAGE, DGAT1 protein could be detected by Coomassie Blue 
staining (Figure 4.3B).  The protein band corresponding to DGAT1 was excised from the gel, 
and digested with trypsin.  The resulting peptides were then identified by MS.  Our preliminary 
MS results suggested that the protein band contained DGAT1, but also over 200 types of 
contaminating proteins that appeared to be more abundant than DGAT1. 
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As mentioned in Section 2.5, DGAT1 is present in crude mitochondrial and microsomal 
fractions. Therefore, to minimize contaminants, FLAG-tagged DGAT1 was 
immunoprecipitated from membrane factions enriched for DGAT1, which were crude 
mitochondria and microsomes prepared by subcellular fractionation.  To further optimize 
immunopurification, prior to incubation with anti-FLAG agarose beads, enriched membrane 
fractions were solubilized with PBS containing two detergents (0.5% SDS and 0.5% Triton X-
100) in the presence of phosphatase and protease inhibitors.  We managed to eliminate most of 
the contaminating proteins through the optimized immunopurification and a single band 
corresponding to DGAT1 was observed (Figure 4.3C). 
 
4.2.2 Identification of PKA Phosphorylation Site(s) of DGAT1 by MS 
To determine the PKA phosphorylation sites of DGAT1, affinity purified DGAT1 from 
Section 4.2.1 was incubated with or without 75 units of PKA.  Following the kinase reaction, 
proteins were separated by SDS-PAGE.  The protein band corresponding to DGAT1 was 
excised from the gel and digested with trypsin.  The resulting peptides were subjected to HPLC-
ESI-MS/MS analysis to identify potential phosphorylation sites.  The molecular weight of 
each peptide was determined by the first MS analyzer.  From the masses of the peptides, a 
peptide map was generated and compared to a previously constructed data base of murine 
DGAT1 tryptic fragments, which was incorporated into the data base search engine Mascot 
(Matrix Science).  Peptides matched for DGAT1 yielded an overall protein sequence coverage 
of 31% (Figure 4.4).   
After characterizing DGAT1 using the initial MS analyzer, each peptide entered 
a collision cell where it was fragmented into individual amino acid residues. The phosphate 
attached to a peptide was also lost during fragmentation, which could be identified by a neutral 
loss of 98 daltons, which is the molecular weight of phosphoric acid (-H3PO4).  As a 
representative example of how specific phosphorylation sites in DGAT1 were assigned, Figure 
4.5 shows the tandem mass spectrum of monophosphorylated peptide TGS17RVSVQGGSGPK.  
This peptide was fragmented in a manner that one amino acid was removed at a time, 
generating a series of peptide fragments with different molecular weights determined by the 
second MS analyzer (Figure 4.5A).  Peptide fragments with molecular weights of 1197.87 
(pink) and 1139.81 (green) daltons showed the neutral loss of 98 daltons respectively, as we
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Control        DGAT1 
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B.                                                                          C. 
 
 
 
Figure 4.3 Immunopurification of DGAT1.   
A: Immunoprecipitation of DGAT1.  FLAG-tagged DGAT1 expressed in McArdle RH7777 
cells was immunoprecipitated from total cell lysate.  Immunoprecipitates were separated by 
SDS-PAGE and immunoblotted for DGAT1 using a monoclonal anti-FLAG antibody.  
McArdle RH7777 cells transfected with the expression vector lacking an insert were used as a 
control.  IP: Immunoprecipitation.   
B and C: Coomassie Staining of DGAT1 Before and After Optimizing Its 
Immunopurification.  FLAG-tagged DGAT1 expressed in McArdle RH7777 cells was 
immunoprecipitated from larger amounts of starting material (cell lysate or crude 
mitochondria+microsomes).  Immunoprecipitates were separated by SDS-PAGE and stained 
with Coomassie Blue.   
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compared them with the corresponding fragments generated in silico (Figure 4.5B).  No more 
neutral loss was observed in any other pair of peptide fragments, suggesting that serine-17 was 
the serine that was phosphorylated.  Serine-20 and -25 were also identified as potential PKA 
phosphorylation sites in a similar manner.  In agreement with our findings, another independent 
research group also reported the identification of serine-17 and -20 as phosphorylation sites 
with >99% certainty (Villén et al., 2007). 
 
1         MGDRGGAGSSRRRRTGSRVSVQGGSGPKVEEDEVRDAAVSPDLGAGGDAPAPAPAPAHTR 
61       DKDGRTSVGDGYWDLRCHRLQDSLFSSDSGFSNYRGILNWCVVMLILSNARLFLENLIKYGI 
121     LVDPIQVVSLFLKDPYSWPAPCVIIASNIFVVAAFQIEKRLAVGALTEQMGLLLHVVNLATIIC 
181     FPAAVALLVESITPVGSVFALASYSIMFLKLYSYRDVNLWCRQRRVKAKAVSTGKKVSGAA 
241     AQQAVSYPDNLTYRDLYYFIFAPTLCYELNFPRSPRIRKRFLLRRVLEMLFFTQLQVGLIQQW 
301     MVPTIQNSMKPFKDMDYSRIIERLLKLAVPNHLIWLIFFYWFFHSCLNAVAELLQFGDREFYR 
361     DWWNAESVTYFWQNWNIPVHKWCIRHFYKPMLRHGSSKWVARTGVFLTSAFFHEYLVSVP 
421     LRMFRLWAFTAMMAQVPLAWIVGRFFQGNYGNAAVWVTLIIGQPVAVLMYVHDYYVLNY 
481     DAPVGV 
 
 
Figure 4.4 Mass Spectrometric Characterization of DGAT1. 
Tryptic peptides were subjected to HPLC-ESI-MS/MS analysis.  Peptides matched for DGAT1 
(highlighted) yielded an overall protein sequence coverage of 31%.  DGAT1 has the consensus 
pattern [R/K](2)-X-[S/T] for PKA phosphorylation site at threonine-15 and serine-244 
(underlined and boldfaced). 
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A. 
 
 
 
B: 
  
G pS R V S V Q G G S G P K 
13 12 11 10 9 8 7 6 5 4 3 2 1 
1295.61 1238.59 1071.59 915.49 816.42 729.39 630.32 502.26 445.24 388.22 301.19 244.17 147.11 
 
Figure 4.5 Mass Spectrometric Analysis of  Potential PKA Phosphorylation Sites.  
A: MS/MS Spectrum of Peptide TGS17RVSVQGGSGPK of DGAT1. 
B: In Silico Spectrum of Peptide TGS17RVSVQGGSGPK of DGATl.  
Numbers represent molecular weights of peptide fragments (e.g. 1238.59 is the molecular 
weight of the fragment SRVSVQGGSGPK). 
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4.3 Determination of Functional Importance of Potential PKA Phosphorylation Sites 
 
4.3.1 The Role of PKA Phosphorylation on DGAT1 Activity and Triacylglycerol 
Synthesis  
To investigate the role of these three potential phosphorylation sites in regulating 
DGAT1 activity, serine-17, -20, and -25 were mutated to alanine.  A triple mutant with all three 
sites mutated to alanine residues was also generated.  DGAT1 mutants, as well as wild-type 
DGAT1, were transiently expressed in HEK293T cells that are widely used for transient protein 
expression (Ho and Pastan, 2009).  Total cellular membranes were prepared and incubated with 
or without PKA.  Proteins were separated by SDS-PAGE and immunoblotted for DGAT1.  
Phosphorylation of DGAT1 by PKA led to an increase of the molecular weight of DGAT1, 
which in turn caused a mobility shift of wild-type DGAT1.  Additionally, mobility shifts were 
observed in the single mutants that are still subject to PKA phosphorylation at the other two 
unmutated sites.  However, the triple mutant displayed little mobility shift (Figure 4.6A), 
suggesting reduced level of PKA phosphorylation.  These results indicate that PKA might 
phosphorylate DGAT1 at multiple sites.  Furthermore, we tested the functional importance of 
these sites for DGAT activity.  In vitro DGAT activity assays were performed in the presence of 
total cellular membranes prepared above.  Unexpectedly, in vitro DGAT activity of the various 
DGAT1 mutants appeared to be similar to that of the wild-type DGAT1, which was 
approximately 12-fold higher than that of untransfected cells, and no inhibition by PKA was 
observed in either wild-type DGAT1 or the mutants (Figure 4.6B). 
We also tested the role of PKA phosphorylation on DGAT1 activity in intact cells.  
HEK293T cells transiently expressing wild-type DGAT1 or the triple mutant were incubated 
with the PKA activator, CPT-cAMP, for 0−90 minutes.  Total cellular membranes were isolated 
from transfected cells, proteins were separated by SDS-PAGE and then immunoblotted for 
DGAT1.  Wild-type DGAT1 and the triple-mutant showed similar expression levels and CPT-
cAMP treatment did not affect the expression level of DGAT1 (Figure 4.7A).  In vitro DGAT 
activity was then measured.  Again, wild-type DGAT1 and the triple mutant exhibited similar in 
vitro DGAT activity that was approximately 10 fold higher than that of untransfected cells, and 
in vitro DGAT activity did not change as incubation time with CPT-cAMP increased (Figure 
4.7B). 
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Figure 4.6 The Effect of PKA Treatment on DGAT Activity in HEK293T Cells. 
A: Mobility Shift of DGAT1 After PKA Treatment.  FLAG-tagged wild-type DGAT1 and 
DGAT1 mutants were transiently expressed in HEK293T cells, total cellular membranes were 
incubated with or without 75 units of PKA.  Proteins were separated by SDS-PAGE and 
immunoblotted for DGAT1 using a monoclonal anti-FLAG antibody. Untransfected HEK293T 
cells were used as a control.  This is a representative result from three independent experiments. 
Un: untransfected; WT: wild-type; TM: triple mutant. 
B: In vitro DGAT Activity of Wild-type DGAT1 and DGAT1 Mutants with or without 
PKA Treatment.  In vitro DGAT activity assays were performed by measuring activity of 50 
µg of protein from total cellular membranes prepared above.  Data are mean + S.D. for triplicate 
analyses from one experiment, which was repeated twice with similar results.   
TG: triacylglycerol.   
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A.      
B. 
             
 
 
 
Figure 4.7 The Effect of cAMP Treatment on DGAT Activity.   
A: Expression of Wild-type DGAT1 and the Triple Mutant with CPT-cAMP Treatment.  
HEK293T cells transiently expressing FLAG-tagged wild-type DGAT1 or the triple mutant 
(S17/20/25A) were incubated with 0.5 mM CPT-cAMP for 0-90 minutes.  Total cellular 
membranes were extracted, proteins were separated by SDS-PAGE and immunoblotted for 
DGAT1 using a monoclonal anti-FLAG antibody. Untransfected HEK293T cells were used as 
control.  This is a representative result of three independent experiments. Un: untransfected.   
B: In vitro DGAT Activity of Wild-type DGAT1 and the Triple Mutant with CPT-cAMP 
Treatment.  In vitro DGAT activity assays were performed by measuring activity of 50 µg of 
protein from total cellular membranes prepared above.  Data are mean + S.D. for triplicate 
analyses from one experiment, which was repeated twice with similar results.  TG: 
triacylglycerol.  
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We further examined the functional importance of these putative phosphorylation sites 
for triacylglycerol synthesis in intact cells.  HEK293T cells transiently expressing wild-type 
DGAT1 or the triple mutant were metabolically labeled with 10 µCi [3H]glycerol for 6 hours to 
determine the amount of newly synthesized triacylglycerol.  Lipids were extracted from cell 
lysates and separated by TLC.  Although wild-type DGAT1 and the triple mutant showed an 
approximately 2-fold increase in triacylglycerol synthesis compared to untransfected cells,  
similar triacylglycerol synthesis was observed from wild-type DGAT1 and the triple mutant 
(Figure 4.8).    
Since the inhibitory effect of PKA on DGAT1 activity and triacylglycerol synthesis was 
initially observed in McArdle RH7777 liver cells stably expressing DGAT1 (Stone et al., 
unpublished observations), we suspected that the role PKA had on DGAT1 activity and 
triacylglycerol synthesis might be cell type dependent. Therefore, instead of investigating 
functional importance of these PKA sites for DGAT1 activity and triacylglycerol synthesis in 
HEK293T cells, wild-type DGAT1 and the triple mutant were transiently expressed in McArdle 
RH7777 liver cells.  Total cellular membranes were prepared, and western blot analysis was 
performed to determine protein expression levels of wild-type DGAT1 and the triple mutant.  It 
was observed that they both were equally expressed in McArdle RH7777 cells (Figure 4.9A).  
In vitro DGAT activity assays were carried out in the presence of total cellular membranes pre-
incubated with or without PKA.  Although in vitro DGAT activity of wild-type DGAT1 and the 
triple mutant was approximately 3-fold higher than that of untransfected cells,  in vitro DGAT 
activity showed no difference between wild-type DGAT1 and the triple mutant in the presence 
or absence of PKA  (Figure 4.9B). 
Since previous studies have demonstrated that DGAT1 exists as a homotetramer (Cheng 
et al., 2001), endogenous DGAT1 in mammalian cells could potentially oligomerize with 
recombinant DGAT1 and confound our studies.  Therefore, DGAT activity of the triple mutant 
was also studied in a mutant yeast strain (H1246MATα) that lacked all four genes contributing 
to triacylglycerol synthesis in yeast, including the gene encoding DGAT1 (Sandager et al., 
2001).  The cDNA encoding FLAG-tagged DGAT1 was cloned into a yeast expression vector 
pYES2 containing a galactose inducible GAL1 promoter.  A triple mutant construct with all 
three putative phosphorylation sites mutated to alanine residues was also generated.  The yeast 
strain H1246MATα was transformed with either construct.  Expression of DGAT1 was induced 
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with galactose for 24 hr.  Transformants were then lysed and total cellular membranes were 
extracted.  Western blot analysis was carried out to examine protein expression levels.  Wild-
type DGAT1 and the triple mutant were expressed at similar levels (Figure 4.10A).  In vitro 
DGAT activity assays were performed using cellular membranes pre-incubated with or without 
PKA.  It was observed that both wild-type DGAT1 and the triple mutant were similarly active 
when expressed in yeast (Figure 4.10B), and showed increased DGAT activity compared to 
untransfected cells (~7-fold).  In addition, there was no apparent difference in DGAT activity 
between PKA treated and non-PKA treated samples. 
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Figure 4.8 De novo Triacylglycerol Synthesis from Wild-type DGAT1 and the Triple 
Mutant in HEK293T Cells.   
HEK293T cells transiently expressing wild-type DGAT1 or the triple mutant (S17/20/25A), as 
well as  untransfected HEK293T cells, were incubated with 10 µCi [3H]glycerol and 0.375mM 
oleic acid complexed to 0.5% BSA for 6 hours. Lipids were extracted from cell lysates and 
separated by TLC.  The incorporation of radioactivity into triacylglycerol was quantified by 
liquid scintillation counting and normalized to total cellular membrane protein content.  Data 
are mean + S.D. for triplicate analyses from one experiment, which was repeated twice with 
similar results.  Un: untransfected; WT: wild-type; TM: triple mutant; TG: triacylglycerol.
[3 H
]T
G
 
fo
rm
ed
 
(C
PM
/m
g 
pr
o
te
in
) 
Un                         WT                       TM 
  
50 
A.                
 
B. 
                          
0
5
10
15
20
25
30
                               
 
Figure 4.9 The Effect of PKA Treatment on DGAT Activity in McArdle RH7777 
Hepatoma Cells.  
A: Expression of Wild-type DGAT1 and the Triple Mutant in McArdle RH7777 Liver 
Cells.  Total cellular membranes were extracted from McArdle cells transiently expressing 
FLAG-tagged wild-type DGAT1 or the triple mutant (S17/20/25A).  Proteins were separated by 
SDS-PAGE and immunoblotted for DGAT1 using a monoclonal anti-FLAG antibody.  
Untransfected McArdle cells were used as control.  This is a representative result from three 
independent experiments. Un: untransfected. * Non-specific protein band. 
B: In vitro DGAT Activity of Wild-type DGAT1 and the Triple-mutant with or without 
PKA Treatment.  In vitro DGAT activity assays were performed by measuring activity of 100 
µg of protein from total cellular membranes pre-incubated with or without 75 units of PKA.  
Data are mean + S.D. for triplicate analyses from one experiment, which was repeated twice 
with similar results.  TG: triacylglycerol.   
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Figure 4.10 The Effect of PKA Treatment on DGAT Activity in the Yeast Strain 
H1246MATα.    
A: Expression of Wild-type DGAT1 and the Triple Mutant in the Yeast Strain 
H1246MATα.  Total cellular membranes were extracted from yeast cells expressing FLAG-
tagged wild-type DGAT1 or the triple mutant (S17/20/25A).  Proteins were separated by SDS-
PAGE and immunoblotted for DGAT1 using a monoclonal anti-FLAG antibody.  Yeast cells 
harbouring an empty pYES2 vector were used as a control.  This is a representative result of 
three independent experiments.  
B: In vitro DGAT Activity of Wild-type DGAT1 and the Triple Mutant with or without 
PKA Treatment.  In vitro DGAT activity assays were performed by measuring activity of 200 
µg of protein from total cellular membranes pre-incubated with or without 75 units of PKA.  
Data are mean + S.D. for triplicate analyses from one experiment, which was repeated twice 
with similar results.  TG: triacylglycerol.   
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4.3.2 The Role of Phosphorylation on DGAT1 Activity   
Since our mutagenesis approach where candidate phosphorylation sites were mutated to 
alanines was not informative, we chose to generate DGAT1 variants that were “permanently” 
phosphorylated. Serine-17, -20, and -25 were mutated to aspartate, whose negative charge 
mimics the phosphorylated state of a protein.  A triple mutant with all three sites mutated to 
aspartates was also generated.  In addition, threonine 15, which had been considered a strong 
candidate for phosphorylation site and rendered DGAT1 hyperactive when mutated to alanine 
(Stone et al., unpublished observations), was mutated to aspartate as well.  DGAT1 mutants as 
well as wild-type DGAT1 were transiently expressed in HEK293T cells, total cellular 
membranes were prepared and proteins were separated by SDS-PAGE and immunoblotted for 
DGAT1.  Wild-type DGAT1 and mutants were expressed at similar levels (Figure 4.11A).  In 
vitro DGAT activity assays were performed.  Again, no significant difference in DGAT activity 
was observed between wild-type and the aspartate mutants (Figure 4.11B).  
 
4.3.3 The Role of PKA Phosphorylation on Multimer Formation of DGAT1  
All the results suggested that these putative phosphorylation sites were not critical for 
DGAT1 activity and triacylglycerol synthesis, indicating that they may be involved in 
regulating other aspects of DGAT1.  Previous studies have illustrated that the N-terminal region 
of DGAT1 is responsible for DGAT1 to form homodimers and homotetramers (Cheng et al., 
2001).  Dephosphorylation of DGAT1 with phosphatase converted homotetramers/dimers of 
DGAT1 to monomers (Stone et al., unpublished observations).  Therefore, we decided to test 
whether these phosphorylation sites residing at the N-terminus played a role in regulating 
DGAT1 multimer formation.  Wild-type DGAT1, the triple alanine mutant, and the triple 
aspartate mutant were transiently expressed in HEK293T cells.  Total cellular membranes were 
prepared and incubated with various concentrations of DSS, which is a homobifunctional, 
membrane permeable, and amine-reactive cross-linker, for 20 min.  Protein samples were then 
separated by SDS-PAGE and immunoblotted for DGAT1.  Both the triple alanine mutant and 
the triple aspartate mutant were still capable of forming dimers and tetramers as wild-type 
DGAT1 was (Figure 4.12), indicating that these phosphorylation sites are not required for 
regulating interactions of DGAT1 subunits. 
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Figure 4.11 DGAT Activity of Wild-type DGAT1 and Aspartate Mutants in HEK293T 
Cells.  
A: Expression of Wild-type DGAT1 and Aspartate Mutants.  Total cellular membranes 
were extracted from HEK293T cells transiently expressing FLAG-tagged wild-type DGAT1 or 
aspartate mutants. Proteins were separated by SDS-PAGE and immunoblotted for DGAT1 
using a monoclonal anti-FLAG antibody.  Untransfected HEK293T cells were used as a control.  
This is a representative result of three independent experiments. Un: untransfected; WT: wild-
type; TM: triple mutant. 
B: In vitro DGAT Activity of Wild-type DGAT1 and Aspartate Mutants.  In vitro DGAT 
activity assays were performed by measuring activity of 50 µg  of protein from total cellular 
membranes prepared above.  Data are mean + S.D. for triplicate analyses from one experiment, 
which was repeated twice with similar results.  TG: triacylglycerol.  
 
 
 
  55 
kDa       
Un        WT        T15D      S17D      S20D      S25D      TM 
 [14
C]
TG
 
fo
rm
ed
 
(pm
o
l/m
in
/m
g) 
 
   Un          WT        T15D      S17D     S20D       S25D       TM 
  
54 
Tetramer 
 
Dimer 
 
 
 
Monomer 
4.3.4 The Role of PKA Phosphorylation on DGAT1 Stability 
Furthermore, we examined whether these PKA phosphorylation sites played a role in 
regulating protein stability of DGAT1.  Wild-type DGAT1 constructs, as well as the triple 
alanine mutant and the triple aspartate mutant, were transiently expressed in HEK293T cells.  
24 hr post-transfection, cells were treated with 100 µg/ml cycloheximide to block protein 
synthesis (Yu et al., 2002a).  To determine the turnover rate of wild-type DGAT1 and the 
mutants, cells were analyzed for the protein level of DGAT1 by Western blot analysis at 
various time points after cycloheximide treatment.  12 hr post cycloheximide incubation, wild-
type DGAT1, as well as both triple mutants, did not display any alteration of protein level 
(Figure 4.13), indicating that DGAT1 is very stable (Yu et al., 2002a) and these 
phosphorylation sites do not have a significant role in the control of DGAT1 turnover.  
 
 
 
                            
 
 
 
 
Figure 4.12 Cross-linking of Wild-type DGAT1 and Triple Mutants with DSS.  
Flag-tagged wild-type DGAT1, the triple alanine mutant (S17/20/25A), and the triple aspartate 
mutant (S17/20/25D) were transiently expressed in HEK293T cells.  Total cellular membranes 
were prepared and incubated with various concentrations of DSS [in DMSO, vehicle 
concentration 2% (v/v)] for 20 min at room temperature.  The reactions were quenched with 1M 
Tris, pH 8.0 (1/10 volume of reaction mixture).  Reaction mixtures were separated by SDS-
PAGE and immunoblotted for DGAT1 using a monoclonal anti-FLAG antibody.  This is a 
representative result of two independent experiments.  WT: wild-type; TM (A): triple alanine 
mutant; TM (D): triple aspartate mutant.   
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4.3.5 The Role of PKA Phosphorylation on Substrate Affinity of DGAT1 
Previous studies have demonstrated that deleting the first 65 amino acids at the N-
terminus of ACAT1, which is homologous to DGAT1, resulted in decreased affinity for oleoyl-
CoA (Yu et al., 2002b).  Although our data suggested that these phosphorylation sites were not 
involved in regulating Vmax of DGAT1, they might have a role in affecting substrate affinity of 
DGAT1.  Therefore, wild-type DGAT1, as well as the triple alanine mutant, were transiently 
expressed in HEK293T cells.  Total cellular membranes were prepared.  In vitro DGAT activity 
assays were carried out with various concentrations of dioleoylglycerol substrate to establish a 
dioleoylglycerol substrate affinity curve of DGAT1.  Wild-type DGAT1 and the triple alanine 
mutant exhibited similar Vmax in the presence of both endogenous and exogenous 
diacylglycerols (Figure 4.14), which is consistent with our previous findings.  However, wild-
type DGAT1 showed higher activity in the presence of endogenous diacylglycerols alone, 
suggesting that wild-type DGAT1 may have higher affinity towards particular endogenous 
diacylglycerol(s). Comparing to the triple alanine mutant, wild-type DGAT1 is still subject to 
PKA phosphorylation, which indicates that PKA phosphorylation may have a role in increasing 
the substrate affinity of DGAT1. 
 
 
 
              
 
 
 
 
Figure 4.13 Turnover Rate of Wild-type DGAT1 and Triple Mutants.  
FLAG-tagged wild-type DGAT1, as well as the triple alanine mutant (S17/20/25A) and the 
triple aspartate mutant (S17/20/25D), were transiently expressed in HEK293T cells.  24 hr post-
transfection, cells were subjected to cycloheximide treatment for various periods of time 
followed by assessment of protein level.  This is a representative result of two independent 
experiments. 
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Figure 4.14 Substrate Affinity of Wild-type DGAT1 and the Triple Alanine Mutant. 
Total cellular membranes were extracted from HEK293T cells transiently expressing wild-type 
DGAT1 or the triple alanine mutant (S17/20/25A).  In vitro DGAT activity assays were 
performed by measuring activity of 50 µg of protein from total cellular membranes with various 
concentrations of dioleoylglycerol.  Data are mean + S.D. for triplicate analyses from one 
experiment, which was repeated once with similar results.  TG: triacylglycerol.  
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5.0 DISCUSSION 
 
 
5.1 DGAT1 Recycling Hypothesis 
As stated in Section 2.9, the first objective of this thesis was to determine the role of 
PKA in regulating DGAT1 activity and triacylglycerol synthesis during lipolysis.  It was 
hypothesized that triacylglycerol synthesis and breakdown are coordinately regulated processes.  
Therefore, during lipolysis, a period of triacylglycerol breakdown, the rate of triacylglycerol 
synthesis in adipose tissue was expected to decrease in order to promote the efficient net release 
of stored energy.  Unexpectedly, in vitro DGAT activity showed a two-fold increase during 
lipolysis in adipocytes, which is opposite to our hypothesis.  This also contradicts previous 
findings that showed in vitro DGAT1 activity of liver or McArdle RH7777 rat hepatoma cells 
overexpressing DGAT1 could be inhibited by PKA.  
However, the increased DGAT activity during lipolysis was consistent with the fatty 
acid recycling hypothesis.  Studies in both animals and humans demonstrated that only 30% of 
the free fatty acids released from triacylglycerol lipolysis in white adipose tissue are delivered 
to peripheral tissues, such as liver and muscle (Reshef et al., 2003).  The other 70% of free fatty 
acids re-enter adipocytes and are re-esterified to triacylglycerols (Figure 5.1).  Further studies 
demonstrated that such recycling occurs not only in adipose tissue but also in liver and skeletal 
muscle (Prentki et al., 2008).  In addition, it is important to note that the percentage of lipolysis-
released free fatty acids that is recycled back to triacylglycerols is relatively constant (~70%) 
under different metabolic conditions (Reshef et al., 2003; Prentki et al., 2008).  In response to 
the increased supply of fatty acids during lipolysis, DGAT1 activity could be stimulated to 
increase triacylglycerol synthesis to prevent free fatty acids from reaching toxic levels and 
producing membrane-damaging effects within the cell.  Moreover, these results are consistent 
with the previous findings showing that DGAT2 is more responsible for promoting bulk 
synthesis of triacylglycerols, while DGAT1 plays more of a role in regulating energy 
metabolism (Figure 5.1) (Stone et al., 2004).   
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Figure 5.1 DGAT1 Recycling Hypothesis.  
Based on the available evidence, DGAT1 is speculated to be involved in the recycling of 
hydrolyzed triacylglycerols by re-esterifying fatty acids, which in turn prevents fatty acids from 
reaching toxic levels and producing membrane-damaging effects within the cell.  On the other 
hand, DGAT2 is more responsible for promoting bulk synthesis of triacylglycerols.  HSL, 
hormone-sensitive lipase; ATGL, adipose-tissue triglyceride lipase; MGL, monoacylglycerol 
lipase; TG: triacylglycerol; DG: diacylglycerol; FA: fatty acid.  The diagram is modified from 
Yen et al. (2008). 
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5.2 Existence of Other Possible PKA Phosphorylation Sites 
Since preliminary studies have identified PKA as one possible kinase that could inhibit 
DGAT1 activity, the major focus of this thesis was to map PKA phosphorylation sites of 
DGAT1 and determine their functional importance with respect to triacylglycerol synthesis.  
The approach was to identify PKA phosphorylation sites by analyzing trypsin digests of affinity 
purified DGAT1 by HPLC-ESI-MS/MS.  Peptides matched for DGAT1 yielded a protein 
sequence coverage of 31%.  Serine-17, -20 and -25 of DGAT1 were identified as potential PKA 
phosphorylation sites.  Although these three sites do not fit the PKA consensus sequence R/K-
R/K-X-S/T (Taylor et al., 1990), serine-17 was previously considered as a “weak” PKA site.  It 
has been demonstrated that the presence of a consensus phosphorylation site does not guarantee 
that the protein is a substrate in vivo, and authentic phosphorylation sites do not always conform 
to the consensus (Ubersax et al., 2003).  Villén et al (2007) also carried out large-scale 
phosphorylation analysis of mouse liver through a combination of tandem phosphopeptide 
enrichment methods, high performance MS, and optimized database search/data filtering 
strategies.  In agreement with our findings, they also reported that serine-17 and -20 of DGAT1 
were phosphorylated with >99% certainty. 
 To determine if serine-17, -20 or -25 had a role in regulating DGAT1 activity and 
triacylglycerol synthesis, we generated DGAT1 mutants in which these amino acids were 
replaced with alanine, and expressed them in mammalian and yeast expression systems 
respectively.   
In HEK293T cells transiently expressing wild-type DGAT1 or various alanine mutants, 
wild-type DGAT1 and single mutants displayed mobility shift caused by PKA phosphorylation. 
However, little shift was observed in the triple mutant with all three PKA sites mutated to 
alanines, suggesting reduced level of PKA phosphorylation.  These results confirm the locations 
of putative PKA phosphorylation sites identified by MS.  These data also indicates that DGAT1 
likely has multiple phosphorylation sites, which is supported by the mass spectrometric 
identification of one tryptic peptide with both serine-20 and -25 being phosphorylated.  From 
our preliminary data, DGAT1 mutants lacking functional PKA sites were expected to be 
resistant to inhibition by PKA, and would have higher DGAT activity and triacylglycerol 
synthesis compared to wild-type DGAT1.  However, in vitro DGAT activity of the various 
DGAT1 mutants appeared to be similar to that of the wild-type DGAT1, and no inhibition by 
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PKA was observed in either wild-type DGAT1 or the mutants.  In HEK293T cells transiently 
expressing wild-type DGAT1 or the triple mutant, DGAT activity of intact cells could not be 
inhibited by treating cells with the PKA activator, CPT-cAMP.  Furthermore, de novo 
triacylglycerol synthesis was measured in intact cells by metabolically labeling cells with 
[3H]glycerol, and wild-type DGAT1 and the triple mutant exhibited similar level of 
triacylglycerol synthesis.  In McArdle RH7777 rat hepatoma cells, where the inhibitory effect 
of PKA on DGAT activity and triacylglycerol synthesis had been initially observed (Stone et 
al., unpublished data), in vitro DGAT1 activity was not different between wild-type DGAT1 
and the triple mutant in the presence or absence of PKA.  All these results suggested that PKA 
phosphorylation at serine-17, -20 and -25 has no apparent effect on the ability of DGAT1 to 
synthesize triacylglycerols.    
All mammalian cells express DGAT1 which may be confounding our studies.  
Therefore, DGAT activity of the triple mutant was also studied in a mutant yeast strain 
(H1246MATα) that lacked all the enzymes that are capable of catalyzing triacylglycerol 
formation.  Wild-type DGAT1 and the triple mutant still displayed similar DGAT1 activity, and 
no PKA inhibition was observed.  These results were consistent with our findings in HEK293T 
cells. 
In addition to analyzing mutations mimicking the dephosphorylated state of DGAT1, 
mutations of threonine-15, serine-17, -20, and -25 to aspartate that mimic the phosphorylated 
state were also examined in HEK293T cells.  As mentioned in Section 4.3.2, threonine-15 was 
included because it has the consensus sequence for a PKA phosphorylation site and rendered 
DGAT1 hyperactive when mutated to alanine.  According to our hypothesis and all the 
preliminary data, DGAT1 mutants mimicking the phosphorylated state of the protein were 
expected to be inhibited, and would have reduced DGAT activity compared to wild-type 
DGAT1.  However, in vitro DGAT activity of the various DGAT1 mutants appeared to be 
similar to that of wild-type DGAT1, which is consistent with the data suggesting that 
phosphorylation at serine-17, -20 and -25 has no apparent effect on DGAT1 activity.  
Although all the results differ from our expectations, they are consistent with those from 
a recent study by McFie et al. (2010), where a particular N-terminal region between amino 
acids 38-84, but not 2-37 of DGAT1, appeared to play a role in regulating DGAT1 activity.  
McFie et al. showed that DGAT activity of a DGAT1 mutant lacking amino acids 2-37 was 
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comparable to that of wild-type DGAT1, whereas DGAT activity of the mutant lacking amino 
acids 2-84 was ~14 fold higher than that of wild-type DGAT1. We speculate that serine-17, -20, 
and -25 are functionally silent in terms of regulating DGAT1 activity and triacylglycerol, and 
PKA might inhibit DGAT1 activity via other unmapped, functionally active phosphorylation 
site(s) between amino acids 38-84.  There are a few serine/threonine amino acids in this region. 
Serine-67 is a potential PKA phosphorylation site as DGAT1 has a weak consensus sequence at 
this amino acid (G-R-T-S67). 
We further investigated whether the three putative phosphorylation sites were involved 
in regulating other aspects of DGAT1 other than activity.  Through cross-linking studies, we 
found that these phosphorylation sites were not required for regulating interactions of DGAT1 
subunits.  Both the triple alanine mutant and the triple aspartate mutant were still capable of 
forming dimers and tetramers as wild-type DGAT1 was.  These findings are consistent with the 
data showing that amino acids 37-84, not 2-37 of DGAT1, are required for DGAT1 tetramer 
formation (McFie et al., 2010).  McFie et al. also speculated that DGAT1 activity may be 
regulated by switching between an active dimer and an inactive tetramer as the inability of 
DGAT1 to form a tetramer corresponded to a several-fold increase in in vitro enzyme activity. 
Taken together, these results indicate that PKA may regulate DGAT1 activity by converting it 
from an active dimer to an inactive tetramer via protein phosphorylation at the region between 
amino acids 37-84. 
Through inhibition of de novo protein synthesis, we also examined whether serine-17,  
-20 or -25 played a role in regulating DGAT1 stability.  It was observed that 12 hours after 
inhibiting protein synthesis with cycloheximide, wild-type DGAT1, as well as both triple 
mutants, did not exhibit any alteration of protein level as determined by immunoblotting.  These 
data are consistent with the previous findings showing that DGAT1 is very stable (Yu et al., 
2002), and also suggest that these three sites are not significant factors in the control of DGAT1 
turnover.   
Lastly, although phosphorylation at the three putative sites has no effect on DGAT1 
activity measured under apparent Vmax conditions described in Section 3.8.3, it played a role in 
regulating the substrate affinity of DGAT1.  Wild-type DGAT1 and the triple alanine mutant 
exhibited similar Vmax in the presence of both endogenous and exogenous diacylglycerols, 
which is in accordance with our previous findings.  However, wild-type DGAT1 showed higher 
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activity with endogenous diacylglycerols alone, indicating that wild-type DGAT1 had higher 
affinity towards endogenous diacylglycerols.  Comparing to the triple alanine mutant, wild-type 
DGAT1 is still subject to PKA phosphorylation.  Therefore, PKA phosphorylation plays a role 
in increasing the substrate affinity of DGAT1.     
 
5.3 Presence of Other Protein Kinases that Phosphorylate DGAT1  
As mentioned in Section 2.7, preliminary experiments demonstrated that DGAT1 could 
be inactivated by a kinase activity present in the cytosol.  Although PKA was proposed to be a 
strong candidate, we cannot exclude the possibility that DGAT1 is phosphorylated and 
regulated by other protein kinases.  As depicted in Figure 4, DGAT1 has several potential PKC 
phosphorylation sites, one AMPK site and one tyrosine kinase site.  In fact, studies performed 
with protein kinase inhibitors suggested that the inhibition of DGAT activity was due to 
tyrosine kinase activity (Lau et al., 1996).  Although mutagenesis experiments indicated that 
this potential tyrosine phosphorylation site did not appear to have a role in regulating DGAT 
activity (Yu et al., 2002), there might be other tyrosine residues that are phosphorylated and 
potentially regulate DGAT activity.  Moreover, Assifi et al. (2005) reported a two-fold increase 
of DGAT activity in rat liver associated with a decrease in AMPK activity during refeeding 
after a fast, prompting speculation that AMPK might be involved in regulating DGAT1 activity 
through phosphorylation.  In addition, the inability of PKA to exert effect on DGAT1 activity 
through the identified phosphorylation sites indicates that DGAT1 is the target of other protein 
kinases. 
 
5.4 Conclusions 
Recent studies have shed light on the metabolic functions of DGAT enzymes, however, 
little is known about the mechanisms responsible for regulating DGAT activity.  Several lines 
of evidence from previous studies indicate that DGAT1, but not DGAT2, is subject to 
regulation by phosphorylation and that protein kinase A (PKA)-dependent pathways are likely 
involved.  In this thesis, we hypothesized that during lipolysis in adipose tissue, PKA would 
phosphorylate and inactivate DGAT1, which in turn would facilitate the efficient net release of 
stored energy by decreasing triacylglycerol synthesis.  In contrast, our experimental results 
showed that in vitro DGAT activity increased 2 fold during lipolysis in 3T3-L1 adipocytes. 
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This data suggests that DGAT activity might increase during lipolysis to promote the 
recycling/re-esterification of excessive free fatty acids into triacylglycerols before they reach 
toxic levels within the cell.  
To further explore the role of PKA in regulating DGAT1, PKA phosphorylation sites of 
DGAT1 were mapped by HPLC-ESI-MS/MS.  Serine-17, -20 and -25 were identified as 
potential PKA phosphorylation sites.  Moreover, the functional importance of these three 
potential phosphorylation sites was investigated.  Mutations of these sites to alanine or aspartate 
residues gave rise to enzymes functioning similarly to wild-type DGAT1.  These 
phosphorylation sites did not appear to be involved in regulating DGAT1 activity, multimer 
formation, or protein stability.   However, PKA phosphorylation at these three sites seemed to 
play a role in affinity of DGAT1 for its diacylglycerol substrate.  These results suggest the 
existence of other unidentified, functionally active PKA phosphorylation sites or 
phosphorylation sites of other kinases, which are involved in regulating DGAT1 activity and 
triacylglycerol synthesis. 
 
5.5 Future Directions 
Unidentified PKA phosphorylation sites should be continuously mapped and examined 
in the same manner as described in this thesis.  Furthermore, to identify potential 
phosphorylation sites of other kinases, DGAT1 should be incubated with mouse liver cytosol, 
in the presence of ATP and magnesium, to promote protein phosphorylation.  We should then 
map the regions of DGAT1 that are phosphorylated in an unbiased manner by HPLC-ESI-
MS/MS.  We should examine the phosphorylation sites and compile a list of candidate kinases 
to test, based on known protein kinase consensus sequences.  The roles of candidate kinases in 
regulating DGAT1 should then be assessed by site-directed mutagenesis experiments.  
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